EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.
Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.
EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.
Contact:
EOS Med Chem, Medicinal Chemical is Big
執大象，天下往，往而無害，安平泰
Ms Nina
Youtube: https://youtu.be/r5cJdXKNXHk
Tel: 0086-531-69905422
SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China
Dichlorodenafil, CAS: 1446089-84-4, stock: 8.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀Cl₂N₄O₂.
Dinitrodenafil, CAS: 1797103-21-9, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₆O₆.
Dithiopropylcarbodenafil, CAS: 2196244-90-1, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄N₆OS₂.
Fondenafil, CAS: 944241-52-5, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂N₆O₃.
Fondenafil-d5, CAS: 1324230-58-1, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇D₅N₆O₃.
Gendenafil, CAS: 147676-66-2, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂N₄O₃.
Homo Sildenafil, CAS: 642928-07-2, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂N₆O₄S.
Homo Sildenafil-d5, CAS: 1216711-61-3, stock: 7.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇D₅N₆O₄S.
Hydroxy Acetildenafil, CAS: 147676-56-0, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄N₆O₄.
Hydroxy Acetildenafil-d4, CAS: /, stock: 2.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀D₄N₆O₄.
Hydroxy Chlorodenafil, CAS: 1391054-00-4, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃ClN₄O₃.
Hydroxyhomo Sildenafil, CAS: 139755-85-4, stock: 4.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂N₆O₅S.
Hydroxythio Acetildenafil, CAS: 1159977-47-5, stock: 6.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄N₆O₃S.
Isobutyl Sildenafil, CAS: 1391053-95-4, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂N₆O₄S.
Methisosildenafil, CAS: 496835-35-9, stock: 5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂N₆O₄S.
Methisosildenafil-d4, CAS: 1246819-66-8, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈D₄N₆O₄S.
Mutaprodenafil, CAS: 1387577-30-1, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₅N₉O₅S₂.
N-Desmethyl Sildenafil, CAS: 139755-82-1, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈N₆O₄S.
Heptakis(6-bromo-6-deoxy)-β-cyclodextrin, CAS: 53784-83-1, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₆₃Br₇O₂₈.
N-Desmethyl Sildenafil Hemicitrate, CAS: /, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₈H₆₄N₁₂O₁₅S₂.
N-Desmethyl Sildenafil-d8, CAS: 1185168-06-2, stock: 6.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀D₈N₆O₄S.
N-Desmethyl Sildenafil-N-β-D-Glucuronide, CAS: /, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₅N₆NaO₁₀S.
N-Desmethyl-N-benzyl Sildenafil, CAS: 1446089-82-2, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄N₆O₄S.
N-Desmethyl-N-benzyl Sildenafil-d5, CAS: /, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₉D₅N₆O₄S.
N-Dimethylaminoethylsulfosildenafil, CAS: /, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀N₆O₃S₂.
Nitrodenafil, CAS: 147676-99-1, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉N₅O₄.
Nor Acetildenafil, CAS: 949091-38-7, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂N₆O₃.
Nor Acetildenafil-d8, CAS: 1185117-07-0, stock: 2.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄D₈N₆O₃.
Norneo Sildenafil, CAS: 371959-09-0, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₉N₅O₄S.
O-Desethyl-O-propyl Methisosildenafil, CAS: 1391053-82-9, stock: 7.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₄N₆O₄S.
O-Desethyl-O-propyl Methisosildenafil-d4, CAS: /, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀D₄N₆O₄S.
Oxohongdenafil, CAS: 1446144-70-2, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂N₆O₄.
Piperazonifil, CAS: 1335201-04-1, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄N₆O₄.
Piperazonifil-d5, CAS: /, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉D₅N₆O₄.
Pyrazolosalicyloyl Imide, CAS: 1798027-05-0, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆N₆O₇S.
Pyrazolosalicyloyl Imide-d3, CAS: /, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃D₃N₆O₇S.
Sildenafil Dimer Impurity, CAS: 1346602-67-2, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₆N₁₀O₈S₂.
Sildenafil N-Oxide, CAS: 1094598-75-0, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₀N₆O₅S.
Sildenafil-d8, CAS: 951385-68-5, stock: 9.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂D₈N₆O₄S.
Thiodimethylsildenafil, CAS: 1260112-90-0, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂N₆O₃S₂.
(1R,4R)-N-Desmethyl Sertraline Hydrochloride, CAS: 675126-09-7, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆Cl₃N.
(1R,4R)-N-Formyl-N-desmethyl Sertraline, CAS: 674768-11-7, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅Cl₂NO.
(1R,4S)-N-Desmethyl Sertraline Hydrochloride, CAS: 675126-08-6, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆Cl₃N.
(1R,4S)-Sertraline Hydrochloride, CAS: 79896-32-5, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈Cl₃N.
(1S,4R) Sertraline Hydrochloride, CAS: 79896-31-4, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈Cl₃N.
(1S,4R)-N-Desmethyl Sertraline Hydrochloride, CAS: 675126-07-5, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆Cl₃N.
(1S,4S)-N-Desmethyl Sertraline Hydrochloride, CAS: 675126-10-0, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆Cl₃N.
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenol, CAS: 167026-37-1, stock: 5.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄Cl₂O.
(4R)-(3’,4’-Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one, CAS: 155748-61-1, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂Cl₂O.
(4S)-(3’,4’-Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one, CAS: 124379-29-9, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂Cl₂O.
(S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenol (Mixture of Diastereomers), CAS: 374777-87-4, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄Cl₂O.
3-Dechloro Sertraline Hydrochloride, CAS: 79646-00-7, stock: 8.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉Cl₂N.
3-Dechloro Sertraline R-Mandelic Acid, CAS: /, stock: 5.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆ClNO₃.
4-(3’,4’-Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one Oxime, CAS: 152642-35-8, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃Cl₂NO.
4-(4-Chlorophenyl)-3,4-dihydro-1(2H)-naphthalenone, CAS: 36159-73-6, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃ClO.
4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline, CAS: 124345-10-4, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂Cl₂O₂.
5-(2,3-Dichlorophenyl)dihydro-2(3H)-furanone, CAS: 1391052-21-3, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈Cl₂O₂.
cis-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro N-Boc-1-naphthalenamine, CAS: 267884-84-4, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃Cl₂NO₂.
N-Methyl Sertraline, CAS: 122873-20-5, stock: 1.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉Cl₂N.
N-[(1R,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenyl]acetamide, CAS: 1097616-52-8, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇Cl₂NO.
N-[(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenyl]acetamide, CAS: /, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇Cl₂NO.
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]-2-methyl-2-propanesulfinamide(Mixture of Diastereomers), CAS: /, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁Cl₂NOS.
rac 4-(2,3-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone, CAS: 152448-80-1, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂Cl₂O.
rac-cis-2,3-Dichloro Sertraline Hydrochloride, CAS: 1198084-29-5, stock: 5.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈Cl₃N.
rac-cis-3,4-Deschlorosertraline, CAS: 52758-05-1, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀ClN.
rac-cis-3-Dechloro Sertraline Hydrochloride, CAS: 79559-98-1, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉Cl₂N.
rac-cis-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenol, CAS: 866018-46-4, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄Cl₂O.
rac-cis-N-Desmethyl Sertraline Hydrochloride, CAS: 91797-57-8, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆Cl₃N.
rac-cis-N-Desmethyl Sertraline-d3 Hydrochloride, CAS: /, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃D₃Cl₃N.
rac-cis-N-Desmethyl Sertraline-d4 Hydrochloride, CAS: /, stock: 2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂D₄Cl₃N.
rac-cis-N-Methyl Sertraline Hydrochloride, CAS: /, stock: 3.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀Cl₃N.
rac-cis-N-Methylphenyl Sertraline Hydrochloride, CAS: /, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂Cl₃N.
5,6,7,8-Tetrahydropteridine, CAS: 10593-78-9, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₄.
rac-trans-3-Dechloro Sertraline Hydrochloride, CAS: 79896-35-8, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈ClN.
rac-trans-N-Desmethyl Sertraline Hydrochloride, CAS: 1310676-34-6, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆Cl₃N.
6-Propionylpterin, CAS: 71014-28-3, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₅O₂.
rac-trans-N-Desmethyl Sertraline-d3 Hydrochloride, CAS: /, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃D₃Cl₃N.
rac-trans-N-Methyl Sertraline Hydrochloride, CAS: 79836-76-3, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀Cl₃N.
Deoxysepiapterin, CAS: 1797-87-1, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁N₅O₂.
L-Sepiapterin, CAS: 17094-01-8, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁N₅O₃.
rac-trans-N-Methyl Sertraline-d6 Hydrochloride, CAS: 2124272-18-8, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄D₆Cl₃N.
L-Sepiapterin-13CD3, CAS: /, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³CH₈D₃N₅O₃.
rac-trans-Sertraline Hydrochloride, CAS: 79617-99-5, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈Cl₃N.
rac-trans-Sertraline-d6 Hydrochloride, CAS: /, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₁D₆Cl₂N • HCl.
Sertraline Carbamoyl Glucuronide, CAS: 119733-44-7, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅Cl₂NO₈.
Sertraline Carbamoyl Glucuronide Methyl Ester, CAS: /, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇Cl₂NO₈.
Sertraline Carbamoyl Glucuronide Methyl Ester Triacetate, CAS: /, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₃Cl₂NO₁₁.
Sertraline-RC 11 Impurity, CAS: 1808266-64-9, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇Cl₂N.
Tametraline, CAS: 52795-02-5, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉N.
trans-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-boc-1-naphthalenamine, CAS: 1217630-23-3, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃Cl₂NO₂.
trans-N-Methylphenyl Sertraline, CAS: /, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₁Cl₂N.
[S(R)]-N-[(4S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]-2-methyl-2-propanesulfinamide, CAS: 674767-90-9, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁Cl₂NOS.
2-{4-[N-(5,6-Diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butyl ester, CAS: 475084-96-9, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₇N₃O₃.
MRE-269, CAS: 475085-57-5, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉N₃O₃.
MRE-269 1-N-Oxide, CAS: /, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉N₃O₄.
Selexipag, CAS: 475086-01-2, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₂N₄O₄S.
Selexipag-d10, CAS: /, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₂D₁₀N₄O₄S.
Selexipag-d8, CAS: 1265295-16-6, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₄D₈N₄O₄S.
(αS)-N-Demethyl Deprenyl, CAS: 56862-30-7, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N.
R-(-)-Deprenyl N-Oxide Hydrochloride Salt, CAS: 830318-01-9, stock: 3.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈ClNO.
R-(-)-Deprenyl-d3 N-Oxide, CAS: 1346616-99-6, stock: 7.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄D₃NO.
R-(-)-N-Demethyl Deprenyl, CAS: 56862-28-3, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N.
R-(-)-N-Demethyl Deprenyl-d5, CAS: 1217977-04-2, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀D₅N.
rac 4-Azido Deprenyl, CAS: 1216800-93-9, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆N₄.
rac 4-Azido Deprenyl-d3, CAS: 1246819-62-4, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃D₃N₄.
(-)-Scopolamine Methyl Bromide, CAS: 155-41-9, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄BrNO₄.
(S)-Tropic Acid, CAS: 16202-15-6, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O₃.
Cimetropium Bromide, CAS: 51598-60-8, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈BrNO₄.
Cimetropium Bromide-d4, CAS: /, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄D₄BrNO₄.
N-Methylaposcopolammonium bromide, CAS: 109668-57-7, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂BrNO₃.
O-Acetyl-(-)-norscopolamine, CAS: 5027-68-9, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁NO₅.
Scopolamine β-D-Glucuronide, CAS: 17660-02-5, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉NO₁₀.
(+)-Isolysergic Acid Diethylamide, CAS: 2126-78-5, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅N₃O.
(+)-Isolysergic Acid Diethylamide (100 μg/mL in Acetonitrile), CAS: 2126-78-5, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅N₃O.
(+)-Isolysergic Acid Diethylamide-d10, CAS: /, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₅D₁₀N₃O.
(-)-2β-Carbomethoxy-3β-(4-(iodophenyl-d4))nortropane, CAS: /, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄D₄INO₂.
(-)-2β-Carbomethoxy-3β-(4-iodophenyl)nortropane, CAS: 136794-87-1, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈INO₂.
(1S,4S)-rel-Ethylsertraline Hydrochloride, CAS: /, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀Cl₃N.
(2,3-Dimethoxyphenyl)-4-piperidinylmethanone Trifluoroacetic Acid Salt, CAS: 139290-73-6, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀F₃NO₅.
(2R)-Hydroxy Sertraline, CAS: /, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇Cl₂NO.
(3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one), CAS: 1159977-04-4, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₄ClN₅OS₂.
(3R)-Aminoquinuclidine Dihydrochloride, CAS: 123536-14-1, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₆Cl₂N₂.
(4-Bromo-2-(hydroxymethyl)phenyl)(4-fluorophenyl-d4)methanone, CAS: /, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₆D₄BrFO₂.
(5,5’-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6’-dichloro-3-hydroxy-3,3’-biindoline-2,2’-dione), CAS: 1303996-68-0, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₄₀Cl₂N₈O₃S₂.
(5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione), CAS: 1159977-56-6, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉ClN₄O₂S.
(R)-(+)-Mianserin, CAS: 78684-63-6, stock: 3.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀N₂.
(R)-(2,3-Dimethoxyphenyl)-4-piperidinemethanol, CAS: 243640-19-9, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁NO₃.
(R)-Citadiol, CAS: 481047-48-7, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃FN₂O₂.
(R,R)-Sertraline, CAS: 79617-98-4, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇Cl₂N.
(R,R)-Sertraline Hydrochloride, CAS: 79645-15-1, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈Cl₃N.
(rac,anti)-4-Deschloro-sertraline, CAS: /, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈ClN.
(rac,syn)-4-Deschloro-sertraline, CAS: /, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈ClN.
(rac,syn)-4-Deschloro-sertraline Hydrochloride, CAS: /, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉Cl₂N.
(S)-(+)-Mianserin, CAS: 51152-88-6, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀N₂.
(S)-5-Bromo-1H-indol-3-yl)(1-methyl-2-pyrrolidinyl)methanone, CAS: /, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅BrN₂O.
(S)-Pramipexole, CAS: 104632-26-0, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₇N₃S.
(S)-Pramipexole N-Methylene Dimer, CAS: /, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₄N₆S₂.
1-(3-Aminophenyl)-3-azetidinecarboxylic Acid Methyl Ester, CAS: 887595-89-3, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O₂.
1-(2-Methyl-1H-benzo[d]imidazol-1-yl)ethanone, CAS: 14678-81-0, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O.
1-(3-Chlorophenyl)biguanide Hydrochloride, CAS: 05/05/2113, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀ClN₅•HCl.
1-Benzyl-4-benzyloxycarbonylaminopiperidine, CAS: 182223-53-6, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄N₂O₂.
1-Boc-4-(2-hydroxymethylphenylamino)piperidine, CAS: 162045-29-6, stock: 8.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆N₂O₃.
Sarafloxacin, CAS: 98105-99-8, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇N₃O₃F₂.
Sarafloxacin Hydrochloride, CAS: 91296-87-6, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈ClF₂N₃O₃.
Sarafloxacin-d8 Hydrochloride, CAS: /, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₀D₈ClF₂N₃O₃.
1-Descyano 1-(4-Dimethylamino)oxobutyl Citadiol, CAS: 1433278-32-0, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₅FN₂O₃.
1-Iodononane (Stabilized with Copper), CAS: 4282-42-2, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉I.
Sarpogrelate Hydrochloride, CAS: 135159-51-2, stock: 10g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂ClNO₆.
2-Amino-N-[1-benzyl-3-(3-tert-butylcarbamoyl-octahydro-isoquinolin-2-yl)-2-hydropropyl]-succinamide, CAS: /, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₆D₉N₅O₄.
epi-Saquinavir, CAS: /, stock: 8.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₅₀N₆O₅.
epi-Saquinavir-d9, CAS: /, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₁D₉N₆O₅.
Saquinavir Hydroxy-tert-butylamide, CAS: 438200-34-1, stock: 10g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₅₀N₆O₆.
Saquinavir Mesylate, CAS: 149845-06-7, stock: 7.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₅₄N₆O₈S.
Saquinavir-d6, CAS: /, stock: 10g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₄D₆N₆O₅.
Saquinavir-d9, CAS: 1356355-11-7, stock: 5.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₁D₉N₆O₅.
1N-Boc-6-cyano-6-norlysergol, CAS: /, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃N₃O₃.
2,2-Dimethyl-3-(4-methoxyphenyl)propanoic Acid, CAS: 29206-06-2, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆O₃.
2,2-Dimethyl-3-(4-methoxyphenyl)propanoic Acid-d6, CAS: /, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀D₆O₃.
2,2’-[(Triphenylmethyl)imino]bisethanol-d4, CAS: /, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₁D₄NO₂.
2,5-Dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine Hydrochloride, CAS: /, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄ClNO₃.
2,5-Dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine-d6 Hydrochloride, CAS: /, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈D₆ClNO₃.
2-(2,5-Dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine Hydrochloride, CAS: 1566571-52-5, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄ClNO₃.
2-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-2,4,5,6-tetrahydro-1H-benz[de]isoquinolin-1-one Hydrochloride, CAS: 135729-66-7, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃ClN₂O.
2-Amino-1-(4-bromo-2,5-dimethoxyphenyl)-ethanone, CAS: 807631-09-0, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂BrNO₃.
2-Amino-4-cyanobenzeneboronic Acid Hydrochloride, CAS: 850568-47-7, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇BN₂O₂•HCl.
2-Methyl Harmine, CAS: 21236-68-0, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅N₂O.
2-Methyl Harmine-d3, CAS: /, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂D₃N₂O.
2-Methyl-5-hydroxytryptamine Hydrochloride, CAS: 845861-49-6, stock: 1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O • HCl.
2-Methylserotonin Maleate Salt, CAS: 78263-91-9, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O • (C ₄H₄O₄).
25I-NBOMe 3-Methoxy Isomer Hydrochloride, CAS: 1566571-63-8, stock: 1.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃ClINO₃.
3,4-Dihydro-4-phenyl-2H-benzo[h]chromene, CAS: 94305-25-6, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆O.
3,4-Dihydro-4-phenyl-2H-benzo[h]chromene-D6, CAS: /, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₀D₆O.
3-(((tert-Butyldimethylsilyl)oxy)methyl)-4-(4-(dimethylamino)butanoyl)benzonitrile, CAS: /, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂N₂O₂Si.
3-Chloroaniline(3-Chlorobenzenamine), CAS: 108-42-9, stock: 4.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClN.
3-Chloro-2,4,6-trideuteroaniline, CAS: 347840-11-3, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃D₃ClN.
3-Chlorobenzenamine-13C6, CAS: /, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₆H₆ClN.
3-Chlorobicyclo[3.2.1]oct-2-ene, CAS: 35242-17-2, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁Cl.
3-Hydroxy Sertraline (Mixture of Diastereomers), CAS: /, stock: 6.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇Cl₂NO.
4-(4-Fluorobenzoyl)-3-hydroxymethylbenzonitrile, CAS: 260371-16-2, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀FNO₂.
4-Methyl-2,3-dihydro-1H-1,5-benzodiazepin-2-one, CAS: 6276-48-8, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O.
4-Benzyloxycarbonylaminopiperidine Hydrochloride, CAS: 207296-89-7, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉ClN₂O₂.
4-Fluorophenethyl Bromide, CAS: 332-42-3, stock: 10g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈BrF.
4-Fluorophenethyl Bromide-d4, CAS: 1189661-61-7, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄D₄BrF.
4-Fluorophenylethanol-d4, CAS: 1189710-73-3, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅D₄FO.
4-Hydroxy Sertraline, CAS: /, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇Cl₂NO.
4-[4-(dimethyl-d6-amino)-1-(4-fluorophenyl)-1-buten-1-yl]-3-(hydroxymethyl)-benzonitrile (Citalopram Olefinic Impurity), CAS: /, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₅D₆FN₂O.
4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-buten-1-yl]-3-(hydroxymethyl)-benzonitrile (Citalopram Olefinic Impurity), CAS: 920282-75-3, stock: 4.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁FN₂O.
4-[4-(Dimethylamino)-1-oxobutyl]-3-(hydroxymethyl)benzonitrile, CAS: 1433278-33-1, stock: 10g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈N₂O₂.
4R-Hydroxy Zolmitriptan, CAS: /, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁N₃O₃.
4S-Hydroxy Zolmitriptan, CAS: /, stock: 7.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁N₃O₃.
5-(1-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)-2-hydroxyethyl)-6-chloroindolin-2-one, CAS: /, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁ClN₄O₂S.
5-(3-Chlorophenyl)dihydro-2(3H)-furanone, CAS: 875256-56-7, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉ClO₂.
3-De(hydroxymethyl)-3-methyl Salmeterol, CAS: 1391054-40-2, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₇NO₃.
Narasin Sodium, CAS: 58331-17-2, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₇₁NaO₁₁.
Salinomycin, CAS: 53003-10-4, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₇₀O₁₁.
5-Hydroxy Pindolol, CAS: /, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀N₂O₃.
4-O-[2-Hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl] Salmeterol, CAS: 1391052-04-2, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₇NO₇.
Salmeterol, CAS: 89365-50-4, stock: 2.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₇NO₄.
Salmeterol Dimer Impurity (Mixture of Diastereomers), CAS: 1391051-88-9, stock: 7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₇₂N₂O₇.
5-Nonyloxytryptamine Oxalate, CAS: 157798-12-4, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₀N₂O.
5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-3-(1-methylethylidene)-2H-indol-2-one, CAS: 684269-12-3, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅ClN₄OS.
6-Chloro-5-(2-chloro-1-hydroxyethyl)-1,3-dihydro-2H-indol-2-one, CAS: 884305-06-0, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉Cl₂NO₂.
6-Hydroxy Pindolol, CAS: /, stock: 6.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀N₂O₃.
6-Nitroquipazine Malate Salt, CAS: 129047-05-8, stock: 4.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄N₄O₂ • ( C₄H₄O₄).
7-Bromoquinoxalin-2(1H)-one, CAS: 82031-32-1, stock: 5.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅BrN₂O.
7-Hydroxy-1,2-dimethyl-9H-pyrido[3,4-b]indolium-d3 Iodide, CAS: /, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀D₃IN₂O.
8-Chlorodibenzo[b,f]thiepin-10(11H)-one, CAS: 1469-28-9, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₉ClOS.
8-Hydroxy Mianserin Hydrochloride, CAS: /, stock: 1.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁ClN₂O.
8-Hydroxy-PIPAT Oxalate, CAS: 1451210-48-2, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂INO • C ₂H₂O₄.
8-Hydroxydemethylclomipramine, CAS: 104061-28-1, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁ClN₂O.
9-Hydroxyclomipramine Hydrochloride, CAS: /, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄Cl₂N₂O.
Amthamine Dihydrobromide, CAS: 142457-00-9, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁N₃S • 2(HBr).
Benzyl[2-(5-hydroxyindol-3-yl)-ethyl]carbamate, CAS: 53157-50-9, stock: 2.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈N₂O₃.
CGS-12066A Maleate Salt, CAS: 1350965-83-1, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇F₃N₄ • C ₄H₄O₄.
Chlorpropham-13C6, CAS: /, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₆H₁₂ClNO₂.
Cinanserin, CAS: 1166-34-3, stock: 8.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄N₂OS.
cis-7,10,13,16-Docosatetraenoic Acid, CAS: 28874-58-0, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₆O₂.
cis-7,10,13,16-Docosatetraenoic Acid Ethyl Ester, CAS: 142828-41-9, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₀O₂.
cis-7,10,13,16-Docosatetraenoic Acid Ethyl Ester-d5, CAS: /, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₅D₅O₂.
Citalopram-oxo Ring Opened Sodium Salt, CAS: /, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀FN₂NaO₃.
CITFP, CAS: 155797-99-2, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃FINO₂.
Clomipramine Hydrochloride (1.0 mg/mL in Methanol), CAS: 17321-77-6, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄Cl₂N₂.
CP 94253 Hydrochloride, CAS: 845861-39-4, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉N₃O • ( HCl).
CP-53631, CAS: 79836-56-9, stock: 4.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉BrClN.
Declenperon, CAS: 63388-37-4, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄FN₃O₂.
Declenperon-d6, CAS: /, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈D₆FN₃O₂.
Delucemine Hydrochloride, CAS: 186495-99-8, stock: 7.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈ClF₂N.
Diethyl 2,2’-(Tritylazanediyl)diacetate, CAS: /, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₉NO₄.
DO3A-Serotonin, CAS: 2125661-93-8, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₈N₆O₈.
Filbanserin, CAS: 167933-07-5, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁F₃N₄O.
Fluperlapine, CAS: 67121-76-0, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀FN₃.
Hexaammineruthenium(III) Trichloride, CAS: 14282-91-8, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Cl₃H₁₈N₆Ru³⁺.
Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one Hydrochloride, CAS: 148091-18-3, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇ClO₂.
Human AANAT(Serotonin N-acetyltransferase) ELISA Kit (96T), CAS: /, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human SERT(Serotonin Transporter) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Hydroxy Ziprasidone, CAS: 884305-08-2, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁ClN₄O₂S.
Hydroxy Ziprasidone-d8, CAS: /, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₃D₈ClN₄O₂S.
Isopropyl 4-Chlorobutyrate, CAS: 3153-34-2, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₃ClO₂.
α-Methyl Serotonin Maleate Salt, CAS: 97469-12-0, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O • C ₄H₄O₄.
Keto Ziprasidone, CAS: 884305-07-1, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉ClN₄O₂S.
L-Tryptophan tert-Butyl Ester Hydrochloride, CAS: 115692-31-4, stock: 6.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁ClN₂O₂.
Lisuride, CAS: 18016-80-3, stock: 8.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆N₄O.
Lisuride Maleate, CAS: 19875-60-6, stock: 5.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆N₄O •C₄H₄O₄.
LY 393558, CAS: 271780-64-4, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁FN₄O₄S₂.
Methyl 2-Bromopropionate, CAS: 5445-17-0, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇BrO₂.
Mianserin Glucuronide, CAS: /, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈N₂O₆.
Mianserin Hydrochloride, CAS: 21535-47-7, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁ClN₂.
Mianserin-d3 Dihydrochloride, CAS: /, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉D₃Cl₂N₂.
Milenperone, CAS: 59831-64-0, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃ClFN₃O₂.
Milenperone-d4, CAS: 1794979-06-8, stock: 2.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉D₄ClFN₃O₂.
Mouse Slc6a4(Sodium-dependent serotonin transporter) ELISA Kit (96T), CAS: /, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
N,N-Di-(tert-Butyloxycarbonyl) Serotonin 2,3,4-tri-O-Acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₄N₂O₁₄.
N,N-Dibenzyloxycarbonyl Serotonin, CAS: 1797983-46-0, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₄N₂O₅.
N-(5-Cyano-1H-indol-3-yl)butyl Vilazodone Acid Ethyl Ester Piperazinium Salt, CAS: /, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₄₃N₆O₃⁺•X⁻.
N-(5-Cyano-1H-indol-3-yl)butyl Vilazodone Piperazinium Salt, CAS: /, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₄₀N⁺N₆O₂•X⁻.
N-(p-Coumaroyl) Serotonin, CAS: 68573-24-0, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈N₂O₃.
N-Acetyl Serotonin β-D-Glucuronide, CAS: 18430-06-3, stock: 4.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂N₂O₈.
N-Acetyl Serotonin Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀N₂O₁₁.
N-Acetyl Serotonin-d4 Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆D₄N₂O₁₁.
N-Acetyl Serotonine O-Sulfate Ester Triethylammonium Salt, CAS: /, stock: 4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂O₅S .(C ₆H₁₅N).
N-Acetyl-N-tert-butoxycarbonyl Serotonin Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₈N₂O₁₃.
N-Acetyl-N-tert-butoxycarbonyl Serotonin-d4 Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₄D₄N₂O₁₃.
N-Allyl-3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine, CAS: 1425793-87-8, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆ClN.
N-Benzyloxycarbonyl Serotonin O-Sulfate, CAS: 85376-01-8, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈N₂O₆S.
N-Benzyloxycarbonyl Serotonin O-Sulfate Sodium Salt, CAS: /, stock: 7.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇N₂NaO₆S.
N-Boc-(2,3-dimethoxyphenyl)-4-piperidinylmethanone, CAS: 139290-71-4, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₅.
N-Boc-N-desmethyl Dapoxetine, CAS: /, stock: 9.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉NO₃.
3,3’-Methylenebis[5-bromo-saligenin, CAS: 875235-19-1, stock: 5.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄Br₂O₄.
3,3’-Methylenebis[5-chlorosaligenin, CAS: 40542-32-3, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄Cl₂O₄.
N-Desmethyl Clomipramine N-Glucuronide, CAS: /, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉ClN₂O₆.
5-Bromo-3-[(5-bromo-2-hydroxyphenyl)methyl]-2-hydroxybenzenemethanol, CAS: 438246-20-9, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂Br₂O₃.
N-Desmethyl N-(3-Dimethylaminopropyl) Clomipramine Dihydrochloride, CAS: /, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄Cl₃N₃.
N-Feruloyl Serotonin, CAS: 68573-23-9, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀N₂O₄.
N,2,2-Trimethoxy-N-methylacetamide, CAS: 1401816-27-0, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO₄.
N-Feruloyl Serotonin-d3, CAS: 1795138-29-2, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇D₃N₂O₄.
N-Hydroxy Sertraline, CAS: 124345-07-9, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇Cl₂NO.
N-Methoxycarbonyl Serotonin, CAS: 77549-09-8, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂O₃.
Salbutamol Acetonide, CAS: 54208-72-9, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅NO₃.
N-Methyl Serotonin Oxalate Salt, CAS: 1975-81-1, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O .(C₂H₂O₄).
N-Methyl Serotonin-d3, CAS: 1794811-18-9, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁D₃N₂O.
N-Methyl Ziprasidone, CAS: 774595-88-9, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃ClN₄OS.
N-Methyl Ziprasidone-d8, CAS: /, stock: 9.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₅D₈ClN₄OS.
N-tert-Butyloxycarbonyl Serotonin 2,3,4-tri-O-Acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₆N₂O₁₂.
N-tert-Butyloxycarbonyl Serotonin β-D-Glucuronide, CAS: /, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈N₂O₉.
N-[3-(1-Naphthalenyloxy)-1-phenylpropyl]carbamic Acid 1,1-Dimethylethyl Ester, CAS: 1404234-03-2, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇NO₃.
((2R,3S,4R,5R)-5-(4-Amino-2-oxo-1,3,5-triazin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Formate, CAS: /, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₄O₆.
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methan-d3-amine, CAS: /, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂D₃Cl₂N.
N’-Boc-N-methoxy-N-methylpiperidine-4-carboxamide, CAS: 139290-70-3, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₄N₂O₄.
Nα-Boc-L-tryptophan, CAS: 13139-14-5, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀N₂O₄.
2,6-Dibromoindosalicylic Acid Disodium Salt, CAS: 112147-27-0, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₅NO₄Br₂-₂.₂[Na+].
Nα-Fmoc-L-tryptophan, CAS: 35737-15-6, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₂N₂O₄.
Nor Mianserin Hydrochloride, CAS: 76134-77-5, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉ClN₂.
NPEC-caged serotonin, CAS: 1257326-22-9, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉N₃O₅.
2-Ethylhexyl Salicylate, CAS: 118-60-5, stock: 2.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₂O₃.
2-Ethylhexyl Salicylate-d4, CAS: /, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈D₄O₃.
3,5-Dibromosalicylaldehyde, CAS: 90-59-5, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄O₂Br₂.
3,5-Diiodosalicylaldehyde, CAS: 2631-77-8, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄O₂I₂.
3-Chloromethyl-5-nitrosalicylaldehyde, CAS: 16644-30-7, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆NO₄Cl.
4-(Dibutylamino)salicylaldehyde, CAS: 57771-09-2, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃NO₂.
4-Isopropylsalicylaldehyde, CAS: 536-32-3, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₂.
Perlapine, CAS: 03/11/1977, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃.
3,5,6-Trichlorosalicylic Acid, CAS: 40932-60-3, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃Cl₃O₃.
Pinacidil Monohydrate, CAS: 85371-64-8, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉N₅•H₂O.
Pindolol Glucuronide, CAS: 93860-29-8, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈N₂O₈.
Bromopentacarbonylrhenium(I), CAS: 14220-21-4, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅BrO₅Re.
3,5-Dibromosalicylic acid, CAS: 3147-55-5, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄Br₂O₃.
3,5-Diiodosalicylic Acid Lithium Salt, CAS: 653-14-5, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃I₂LiO₃.
3,5-Diisopropylsalicylic Acid, CAS: 2215-21-6, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈O₃.
Pirenperone, CAS: 75444-65-4, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₄FN₃O₂.
3,6-Dichlorosalicylic Acid (Dcsa) (Ring-13c6, 99%), CAS: 1173019-34-5, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C¹³C₆H₄Cl₂O₃.
R(+)-UH-301, CAS: 127126-18-5, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄FNO.
R-96544 Hydrochloride, CAS: 167144-80-1, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₉NO₃ • (HCl).
rac (2,3-Dimethoxyphenyl)-4-piperidinemethanol, CAS: 140235-25-2, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁NO₃.
4-Ethoxysalicylic Acid, CAS: 10435-55-9, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O₄.
3-Chloromethyl-5-methylpyridine Hydrochloride, CAS: 1007089-84-0, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉Cl₂N.
5’-[(Desloratadine)methyl] Rupatadine, CAS: 1224515-72-3, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₄₃Cl₂N₅.
5’-[(Desloratadine)methyl] Rupatadine-d8, CAS: 1794669-33-2, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₃₅D₈Cl₂N₅.
5,5’-Thiodisalicylic Acid, CAS: 1820-99-1, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀O₆S.
5-Acetylsalicylic Acid, CAS: 13110-96-8, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈O₄.
5-Fluorosalicylic acid, CAS: 345-16-4, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅FO₃.
5-Methoxysalicylic acid, CAS: 04/02/2612, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈O₄.
rac-cis-Sertraline Hydrochloride, CAS: 79617-89-3, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈Cl₃N.
rac-trans Sertraline-d3 Hydrochloride, CAS: 1330180-66-9, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅D₃Cl₃N.
Rat Aanat(Serotonin N-acetyltransferase) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Slc6a4(Sodium-dependent serotonin transporter) ELISA Kit (96T), CAS: /, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Arazine, CAS: 135304-07-3, stock: 1.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₃NO₃S.
Ritanserin, CAS: 87051-43-2, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₅F₂N₃OS.
Di-o-anisamide-d6, CAS: /, stock: 4.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₉D₆NO₄.
RS-127445 Hydrochloride, CAS: 199864-86-3, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇ClFN₃.
Diethylamine Salicylate, CAS: 4419-92-5, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆O₃• C₄H₁₁N.
RuBi-5-HT, CAS: /, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₇F₁₂N₆OP₃Ru.
Ginkgolic Acid, CAS: 20261-38-5, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O₃.
S(-)-UH-301 Hydrochloride, CAS: 127126-22-1, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄FNO •HCl.
Glycol Salicylate, CAS: 87-28-5, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O₄.
Homosalate, CAS: 118-56-9, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂O₃.
Homosalate-d4, CAS: /, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈D₄O₃.
SDZ SER 082 Fumarate, CAS: 1417343-80-6, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄N₂O₄.
Serotonin Hydrochloride, CAS: 153-98-0, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃ClN₂O.
Serotonin Hydrogen Maleate, CAS: 18525-25-2, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆N₂O₅.
Serotonin Hydrogenoxalate, CAS: 3036-16-6, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₂O •C ₂H₂O₄.
Serotonin β-D-Glucuronide, CAS: 18186-43-1, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀N₂O₇.
Serotonin O-Sulfate, CAS: 16310-20-6, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₂O₄S.
Serotonin-13C215N, CAS: /, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³C₂H₁₂N¹⁵NO.
Methyl 3,5-Dinitrosalicylate, CAS: 22633-33-6, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆N₂O₇.
Serotonin-d4 Hydrochloride, CAS: /, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉D₄ClN₂O.
Serotonin-d4 β-D-Glucuronide, CAS: /, stock: 8.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆D₄N₂O₇.
Sertraline Hydrochloride, CAS: 79559-97-0, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈Cl₃N.
Sertraline Hydrochloride (1.0 mg/mL in Methanol), CAS: 79559-97-0, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈Cl₃N.
Sertraline-13C, 15N, d3 Hydrochloride, CAS: /, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆¹³CH₁₅D₃Cl₃¹⁵N.
Sertraline-d3 Hydrochloride, CAS: 1217741-83-7, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅D₃Cl₃N.
Sertraline-d6 Hydrochloride, CAS: /, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₁D₆Cl₂N • HCl.
Sertraline-N-methylacetamide, CAS: 1413642-93-9, stock: 4.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉Cl₂NO.
Methyl Formate, CAS: 107-31-3, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₄O₂.
Methyl Formate-d, CAS: 23731-38-6, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₃DO₂.
Methyl Propiolate, CAS: 922-67-8, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄O₂.
Methylenedisalicylic Acid (mixture of isomers), CAS: 27496-82-8, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₆.
N-(3-Methoxyphenyl)acetamide-d4, CAS: /, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇D₄NO₂.
TCB-2, CAS: 912342-28-0, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄BrNO₂ • HBr.
Telotristat Ethyl, CAS: 1033805-22-9, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₆ClF₃N₆O₃.
Trachelanthamidine, CAS: 526-64-7, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅NO.
Tri-o-tolyl-Phosphine Oxide, CAS: 6163-63-9, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁OP.
Parcetasal, CAS: 87549-36-8, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅NO₅.
Phenyl 2-Hydroxy-4-methoxy-5-sulfobenzoate, CAS: /, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂O₇S.
Phenyl 2-Hydroxy-4-methoxy-5-sulfobenzoate-d5, CAS: /, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₇D₅O₇S.
Salicylic Acid Acyl Glucoside, CAS: 60517-74-0, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆O₈.
Salicylic Acid Acyl-β-D-glucuronide, CAS: 29315-53-5, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄O₉.
Volinanserin, CAS: 139290-65-6, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈FNO₃.
Volinanserin Hydrochloride Salt, CAS: /, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₉ClFNO₃.
Volinanserin-d4 Hydrochloride Salt, CAS: 1217617-73-6, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅D₄ClFNO₃.
WAY 161503 Hydrochloride, CAS: 276695-22-8, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁Cl₂N₃O • (HCl).
WAY 629 Hydrochloride, CAS: 57756-44-2, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈N₂ • HCl.
Zimeldine, CAS: 56775-88-3, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇BrN₂.
Zimeldine-d6, CAS: 1185239-75-1, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₁D₆BrN₂.
Ziprasidone Hydrochloride Monohydrate, CAS: 138982-67-9, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄Cl₂N₄O₂S.
Ziprasidone N-Oxide, CAS: 188797-76-4, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁ClN₄O₂S.
Ziprasidone N-Oxide-d8, CAS: /, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₃D₈ClN₄O₂S.
Ziprasidone-d8, CAS: 1126745-58-1, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₃D₈ClN₄OS.
Zolmitriptan Namino-sucraloside (Mixture), CAS: /, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₀Cl₃N₃O₁₀.
Zotepine, CAS: 26615-21-4, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈ClNOS.
Zotepine N,S-Dioxide, CAS: 1514918-29-6, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈ClNO₃S.
Zotepine N,S-Dioxide-d6, CAS: /, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₂D₆ClNO₃S.
Rufloxacin Hydrochloride, CAS: 106017-08-7, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉ClFN₃O₃S.
Zotepine N-Oxide, CAS: 63720-83-2, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈ClNO₂S.
Zotepine N-Oxide-d6, CAS: /, stock: 3.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₂D₆ClNO₂S.
Rufloxacin-d3 Hydrochloride, CAS: /, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆D₃ClFN₃O₃S.
Zotepine S-Oxide, CAS: 78105-23-4, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈ClNO₂S.
Zotepine S-Oxide-d6, CAS: /, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₂D₆ClNO₂S.
Zotepine-d6, CAS: /, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₂D₆ClNOS.
1-[(1R)-2-(2,4-Dihydroxyphenyl)-1-(3,5-dihydroxyphenyl)-2-oxoethyl]-3-[(S)-pyrrolidin-2-yl]urea, CAS: /, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O₆.
2-C-Methyl-D-ribono-1,4-lactone, CAS: 492-30-8, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀O₅.
3-Bromopiperidin-2,6-dione, CAS: 62595-74-8, stock: 1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆BrNO₂.
3-Oxo-1,2-benzoisothiazoline-2-acetic Acid Methyl Ester 1,1-Dioxide(Piroxicam Impurity D), CAS: 6639-62-9, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO₅S.
7-Methylsaccharin, CAS: 136526-27-7, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO₃S.
Denatonium Saccharide, CAS: 90823-38-4, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₃N₃O₄S.
Isosaccharinic Acid-1,4-lactone, CAS: 7397-89-9, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀O₅.
N-(α,α-Dimethylbenzyl)-2-formyl-benzenesulfonamide-13C6, CAS: /, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀¹³C₆H₁₇NO₃S.
N-(α,α-Dimethylbenzyl)benzenesulfonamide, CAS: 66898-01-9, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇NO₂S.
N-(α,α-Dimethylbenzyl)benzenesulfonamide-13C6, CAS: 1287138-19-5, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³C₆H₁₇NO₂S.
N-Bromosaccharin, CAS: 35812-01-2, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄NO₃SBr.
N-Formylsaccharin, CAS: 50978-45-5, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₄S.
N-Iodosaccharin, CAS: 86340-94-5, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄INO₃S.
o-Toluenesulfonamide, CAS: 88-19-7, stock: 2.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₂S.
o-Toluenesulfonamide-d7, CAS: /, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₂D₇NO₂S.
Saccharin, CAS: 81-07-2, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NO₃S.
Saccharin N-(2-Acetic Acid Ethyl Ester)(Piroxicam Impurity E), CAS: 24683-20-3, stock: 5.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁NO₅S.
Saccharin N-(2-Acetic Acid Isopropyl Ester)(Piroxicam Impurity F), CAS: 76508-37-7, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃NO₅S.
Saccharin Sodium Salt Dihydrate, CAS: 6155-57-3, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄NNaO₃S • 2(H ₂O).
Saccharin-13C6, CAS: 1286479-01-3, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C¹³C₆H₅NO₃S.
Saccharin-d4, CAS: 1189466-17-8, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇HD₄NO₃S.
Sodium Saccharine, CAS: 128-44-9, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NNaO₃S.
2,6-Didesfluoro Rufinamide, CAS: 80819-65-4, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₄O.
4-Descarboxamido Rufinamide 4-Methyl Ester, CAS: 217448-86-7, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉F₂N₃O₂.
6-Desfluoro Rufinamide, CAS: 106308-41-2, stock: 1.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉FN₄O.
6-Desfluoro Rufinamide-d2, 15N1, CAS: /, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇D₂FN₃¹⁵NO.
Rufinamide, CAS: 106308-44-5, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈F₂N₄O.
Rufinamide-15N,d2, CAS: 1795037-48-7, stock: 9.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆D₂F₂N₃¹⁵NO.
Rufinamide-d2, CAS: /, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆D₂F₂N₄O.
Ruboxistaurin Hydrochloride, CAS: 169939-93-9, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₉ClN₄O₃.
Ruboxistaurin-d6 Hydrochloride, CAS: 1794767-04-6, stock: 6.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₃D₆ClN₄O₃.
Erythromycin 4’’-O-TES 10-Imino-N-(2-Methoxyethoxy)methanol, CAS: /, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₇H₉₀N₂O₁₅Si.
Erythromycin 4’’-O-TES 10-Imino-N-hydroxyl, CAS: /, stock: 3.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₈₂N₂O₁₃Si.
Erythromycin N-2-Propenyl Bromide, CAS: /, stock: 9.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₇₂N⁺O₁₃•Br⁻.
Erythromycin-d3 A 9-Oxime, CAS: /, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₅D₃N₂O₁₃.
N-Demethyl Roxithromycin, CAS: 118267-18-8, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₇₄N₂O₁₅.
N-Demethyl Roxithromycin-d7, CAS: /, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₆₇D₇N₂O₁₅.
O-[(2-Methoxyethoxy)methyl]-hydroxylamine, CAS: 113952-50-4, stock: 3.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₁NO₃.
Roxithromycin, CAS: 80214-83-1, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₇₆N₂O₁₅.
Roxithromycin (1.0 mg/mL in Methanol), CAS: 80214-83-1, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₇₆N₂O₁₅.
Roxithromycin-d7, CAS: /, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₆₉D₇N₂O₁₅.
Roxatidine Acetate Hydrochloride, CAS: 93793-83-0, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈N₂O₄ • HCl.
Roxatidine Acetate Hydrochloride, CAS: 98793-83-0, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈N₂O₄ • HCl.
Roxatidine Hemioxalate, CAS: 110925-92-3, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆N₂O₃•1/2C₂H₂O₄.
Roxatidine-d10 Hemioxalate, CAS: 1794756-35-6, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆D₁₀N₂O₃•1/2C₂H₂O₄.
Rotundine, CAS: 483-14-7, stock: 8.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅NO₄.
(R)-(+)-Ropivacaine Hydrochloride, CAS: 112773-90-7, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇ClN₂O.
(S)-2-(2,6-Dimethylphenyl)-3,3-dimethyl-d6-hexahydroimidazo[1,5-a]pyridin-1(5H)-one, CAS: /, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈D₆N₂O.
(S)-2-(2,6-Dimethylphenyl)-3,3-dimethylhexahydroimidazo[1,5-a]pyridin-1(5H)-one, CAS: /, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄N₂O.
(S)-Ropivacaine, CAS: 84057-95-4, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆N₂O.
(S)-Ropivacaine N-Isopropyl, CAS: 265120-58-9, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆N₂O.
(S)-Ropivacaine N-Isopropyl-d7, CAS: /, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉D₇N₂O.
2,6-Dimethylaniline Hydrochloride, CAS: 21436-98-6, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂ClN.
3-Amino Ropivacaine, CAS: 247061-08-1, stock: 10g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇N₃O.
3-Hydroxy Ropivacaine, CAS: 163589-30-8, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆N₂O₂.
3-Nitro Ropivacaine, CAS: 247061-07-0, stock: 2.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₅N₃O₃.
4-Acetyloxy-N-despropyl N-tert-Butyloxycarbonyl Ropivacaine, CAS: 1391053-36-3, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀N₂O₅.
4-Acetyloxy-N-despropyl Ropivacaine, CAS: 1797399-64-4, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₂N₂O₃.
4-Hydroxy Ropivacaine, CAS: 163589-31-9, stock: 7.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆N₂O₂.
4-Hydroxy-N-despropyl N-tert-Butyloxycarbonyl Ropivacaine, CAS: 1391053-93-2, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈N₂O₄.
4-Hydroxy-N-despropyl Ropivacaine, CAS: 243989-47-1, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀N₂O₂.
N-2-Desmethyl Ropivacaine, CAS: 98626-59-6, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄N₂O.
N-2-Desmethyl Ropivacaine-d5, CAS: /, stock: 5.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉D₅N₂O.
Ropivacaine Hydrochloride Monohydrate, CAS: 132112-35-7, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₉ClN₂O₂.
Ropivacaine N-Oxide, CAS: 1391053-59-0, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆N₂O₂.
Ropivacaine-d7 Hydrochloride, CAS: 1217667-10-1, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀D₇ClN₂O.
Ropivacaine-d7 N-Oxide, CAS: 1795786-47-8, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉D₇N₂O₂.
(6R)-5,6,7,8-Tetrahydro-6-(propylamino)-1-naphthalenol, CAS: 101470-24-0, stock: 1.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉NO.
(6S)-5,6,7,8-Tetrahydro-6-(propylamino)-1-naphthalenol, CAS: 101470-23-9, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉NO.
(R)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine L-Tartrate Salt, CAS: /, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₇NO₇.
(S)-5,6,7,8-Tetrahydro-6-(propylamino)-1-naphthalenol Hydrogen Sulfate Ester, CAS: 154714-31-5, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉NO₄S.
(S)-5-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine Hydrochloride, CAS: 58349-17-0, stock: 1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO •HCl.
2-Thiopheneethanol Tosylate, CAS: 40412-06-4, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄O₃S₂.
5-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine, CAS: 4018-91-1, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO.
Despropylrotigotine, CAS: 153409-14-4, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉NOS.
ent-Rotigotine, CAS: 112835-48-0, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅NOS.
N-Despropyl Rotigotine Sulfate, CAS: 1196459-54-7, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉NO₄S₂.
rac Rotigotine-d3 Hydrochloride Salt, CAS: 1215846-20-0, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₃D₃ClNOS.
rac Rotigotine-d7 Hydrochloride, CAS: /, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉D₇ClNOS.
rac-Rotigotine Hydrochloride, CAS: 102120-99-0, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆ClNOS.
Rotigotine Hydrochloride, CAS: 125572-93-2, stock: 2.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆ClNOS.
Rotigotine β-D-Glucuronide, CAS: 128464-29-9, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃NO₇S.
Rotigotine Sulfate, CAS: 128478-69-3, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅NO₄S₂.
1,4-Diethylindolin-2-one, CAS: /, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO.
2-(3-Acetamidophenyl)-N,N-dipropylacetamide, CAS: /, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄N₂O₂.
2-Methyl-3-nitrobenzeneethanol, CAS: 855382-76-2, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₃.
2-[2-(Di-N-propylamino)ethyl]-6-nitrophenyl Acetic Acid-N-oxide, CAS: /, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄N₂O₅• HCl.
2-[2-(Dipropylamino)ethyl]-6-nitrophenyl Acetic Acid Hydrochloride, CAS: 91374-25-3, stock: 6.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅ClN₂O₄.
2-[2-(Dipropylamino)ethyl]-6-nitrophenyl Acetic Acid Methyl Ester Hydrochloride, CAS: /, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇ClN₂O₄.
3,4-Dihydro-1H-cyclopenta[cd]indol-2(2aH)-one, CAS: 1368745-05-4, stock: 7.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO.
3-(2-(Dipropylamino)ethyl)-N-ethylaniline, CAS: /, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₈N₂.
3-Amino-N,N-diethyl-benzeneethanamine, CAS: 932394-03-1, stock: 9.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀N₂.
3-Amino-N,N-dipropyl-benzeneethanamine Hydrochloride, CAS: 1797105-94-2, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₅ClN₂.
3-Amino-2-methyl-N,N-dipropylbenzeneethanamine, CAS: 111725-11-2, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆N₂.
3-Hydroxyimino Ropinirole, CAS: /, stock: 7.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃N₃O₂.
3-Methoxy Ropinirole Hydrochloride, CAS: 1797131-21-5, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇ClN₂O₂.
3-Methylene Ropinirole, CAS: /, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄N₂O.
4-(2-(Dipropylamino)ethyl)-1-ethyl-3,3-bis(methylthio)indolin-2-one, CAS: /, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂N₂OS₂.
4-(2-(Dipropylamino)ethyl)-3,3-bis(methylthio)indolin-2-one, CAS: /, stock: 5.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈N₂OS₂.
4-(2-Aminoethyl)-1,3-dihydro-2H-indol-2-one Hydrochloride, CAS: 91374-26-4, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃ClN₂O.
4-(2-Azidoethyl)-1,3-dihydro-2H-indol-2-one, CAS: 157649-58-6, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₄O.
4-(2-Hydroxyethyl)-1,3-dihydro-2H-indolin-2-one, CAS: 139122-19-3, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NO₂.
4-Ethenyl-1,3-dihydro-2H-indol-2-one, CAS: 120427-93-2, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO.
4-Ethyl-1,3-dihydro-2H-indol-2-one, CAS: 954117-24-9, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NO.
4-[2-[[(4-Methylphenyl)sulfonyl]oxy]ethyl]-1,3-dihydroindol-2-one, CAS: 139122-20-6, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇NO₄S.
Decarbonyl Ropinirole Dihydrochloride, CAS: 1346603-36-8, stock: 1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈Cl₂N₂O.
Ethyl Ropinirole, CAS: 1797132-03-6, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈N₂O.
N,N-Diethyl-3-nitrobenzeneacetamide, CAS: 19281-11-9, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆N₂O₃.
N,N-Dipropyl-3-nitro-benzeneethanamine, CAS: 97351-96-7, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂N₂O₂.
N,N-Dipropyl-3-nitrobenzeneacetamide, CAS: 97351-97-8, stock: 7.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀N₂O₃.
N-Desbispropyl-N-pentyl-2-methyl Ropinirole, CAS: 249622-60-4, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄N₂O.
N-Despropyl Ropinirole, CAS: 106916-16-9, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈N₂O.
N-Despropyl Ropinirole Hydrochloride, CAS: 173990-76-6, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉ClN₂O.
N-Despropyl Ropinirole-d3, CAS: 1215798-00-7, stock: 5.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅D₃N₂O.
N-Hydroxy Ropinirole Hydrochloride, CAS: 1542267-72-0, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅ClN₂O₂.
N-Methoxy Ropinirole Hydrochloride, CAS: 1796934-24-1, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆N₂O₂ (HCl).
Propylidine Ropinirole Hydrochloride(E/Z-Mixture), CAS: 221264-43-3, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉ClN₂O.
Ropinirole Aldehyde, CAS: /, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄N₂O₂.
Ropinirole Aminoacetic Acid, CAS: 920755-10-8, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₆N₂O₂.
Ropinirole Aminoacetic Acid-d4 Dihydrochloride, CAS: 1346605-07-9, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄D₄Cl₂N₂O₂.
Ropinirole Hydrochloride, CAS: 91374-20-8, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅ClN₂O.
Ropinirole N,N-Methylene Dimer, CAS: /, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₈N₄O₂.
Ropinirole N-Oxide, CAS: 1076199-41-1, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₄N₂O₂.
Ropinirole-d4 Hydrochloride, CAS: 1330261-37-4, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁D₄ClN₂O.
Ropinirole-d7 Hydrochloride, CAS: 1261396-31-9, stock: 8.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈D₇ClN₂O.
Sumanirole Maleate, CAS: 179386-44-8, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇N₃O₅.
2-Fluoro-2’-deoxyadenosine, CAS: 21679-12-9, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂FN₅O₃.
Metronidazole β-D-Glucuronide, CAS: 100495-98-5, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇N₃O₉.
N-(2-Hydroxyethyl)-5-methyl-1,2,4-oxadiazole-3-carboxamide, CAS: 110578-73-9, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉N₃O₃.
Secnidazole Formate, CAS: /, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁N₃O₄.
Silver Tetrafluoroborate, CAS: 14104-20-2, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: AgBF₄.
Rolapitant Hydrochloride, CAS: 858102-79-1, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆F₆N₂O₂ •HCl.
Rolapitant Hydrochloride Hydrate, CAS: 914462-92-3, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆F₆N₂O₂ • (HCl) • (H ₂O).
[(1S)-1-[[[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethyl]oxy]methyl]-1-phenylprop-2-enyl]amine Monomaleate, CAS: 1214741-14-6, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉F₆NO • (C ₄H₄O₄).
5-Hydroxy Vioxx, CAS: 185147-17-5, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₅S.
(2α,3α,5α)-2,3-Epoxy-androst-16-en-17-ol Acetate, CAS: 212505-49-2, stock: 4.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀O₃.
(2β,3α,5α,16β,17β)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane, CAS: 119302-24-8, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₈N₂O₄.
(2β,3α,5α,16β,17β)-2,16-di-1-Pyrrolidinylandrostane-3,17-diol, CAS: 144209-33-6, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₆N₂O₂.
(2β,3α,5α,16β,17β)-2,16-di-1-Pyrrolidinylandrostane-3,17-diol 17-Acetate, CAS: 1190105-60-2, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₈N₂O₃.
(2β,3α,5α,16β,17β)-2,16-di-1-Pyrrolidinylandrostane-3,17-diol 3,17-Diacetate, CAS: 1190105-62-4, stock: 5.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₅₀N₂O₄.
(2β,3α,5α,16β,17β)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol, CAS: 119302-20-4, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₆N₂O₃.
(5α)-Androsta-2,16-dien-17-ol 17-Acetate, CAS: 50588-42-6, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀O₂.
1,2-Dehydro-3-oxo Desallyl Rocuronium, CAS: /, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₄N₂O₄.
1,2-Dehydro-3-oxo Rocuronium Bromide, CAS: 1190105-67-9, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₉BrN₂O₄.
1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-Acetoxy-2-(N-(2-(formyloxy)ethyl)formamido)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-allylpyrrolidin-1-ium Bromide, CAS: /, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₅₁BrN₂O₆.
17-Desacetyl Rocuronium Bromide, CAS: 119302-86-2, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₁BrN₂O₃.
2-Allylpyrrolidinyl-3-acetyl Desmorpholinylrocuronium Dibromide, CAS: /, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₀Br₂N₂O₄.
2-Pyrrolidinyl Desmorpholinylrocuronium Bromide, CAS: 1190105-65-7, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₅₃BrN₂O₃.
2-Pyrrolidinyl-3-acetyl Desmorpholinylrocuronium Bromide, CAS: 1190105-66-8, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₅₅BrN₂O₄.
3-Acetoxy 4-Pyrrolidinyl 17-Hydroxy Rocuronium Bromide, CAS: /, stock: 10g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₅₃BrN₂O₃.
3-Acetyl Rocuronium Bromide, CAS: 122483-73-2, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₅₅BrN₂O₅.
3-Acetyl-17-deacetyl Rocuronium Bromide, CAS: 1190105-63-5, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₅₃BrN₂O₄.
3-Acetyl-d3 Rocuronium Bromide, CAS: /, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₅₂D₃BrN₂O₅.
3-Oxo Desallyl Rocuronium, CAS: /, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₆N₂O₄.
Rocuronium Bromide, CAS: 119302-91-9, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₅₃BrN₂O₄.
Rocuronium Bromide N-Oxide, CAS: /, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₅₃BrN₂O₅.
2-(1-Hydroxy-3-butynyl)-4-(1,2,4-triazolylmethyl)aniline, CAS: 1329797-47-8, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄N₄O.
3-Iodo-4-aminobenzotriazole, CAS: 160194-26-3, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉IN₄.
3-Iodo-N-tosyl-4-aminobenzotriazole, CAS: 1329835-01-9, stock: 4.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅IN₄O₂S.
N-Didemethyl Rizatriptan N,N,N-Triethylammonium Chloride, CAS: /, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈ClN₅.
Rizatriptan Bismethylammonium Chloride Dimer, CAS: /, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₂ClN₉.
Rizatriptan N-Methylsulfonamide, CAS: /, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁N₅O₂S.
1-(3-Methoxyphenyl)ethanol, CAS: 23308-82-9, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂O₂.
(5-Chloro-2-thienyl)(3-hydroxy-1-azetidinyl)methanone, CAS: 1341527-09-0, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈ClNO₂S.
(R)-2-(2-((4-((3-(5-Chlorothiophene-2-carboxamido)-2-hydroxypropyl)amino)phenyl)amino)ethoxy)acetic Acid, CAS: /, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂ClN₃O₅S.
2-(((4-(5-((5-Chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)methoxy)acetic Acid, CAS: /, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈ClN₃O₆S.
2-(2-((4-((3-(5-Chlorothiophene-2-carboxamido)-2-hydroxypropyl)amino)phenyl)amino)ethoxy)acetic Acid, CAS: /, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂ClN₃O₅S.
2-[2-[[4-[(5S)-5-[[[(5-Chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]amino]ethoxy]-acetic Acid Hydrochloride, CAS: 931117-61-2, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀ClN₃O₆S • H Cl.
2-Chlorothiophene-3-carboxylic Acid, CAS: 53935-71-0, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃ClO₂S.
2-Hydroxy-3-oxo-Rivaroxaban, CAS: 1160169-99-2, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₆S.
2-Hydroxy-5-oxo-Rivaroxaban, CAS: 1160169-96-9, stock: 1.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₆S.
2-[[4-[(5S)-5-[[[(5-Chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl](2-hydroxyethyl)amino]-2-oxo-acetic Acid, CAS: 1160169-98-1, stock: 10g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₇S.
3-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide, CAS: 1855920-54-5, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₅S.
3-Hydroxy Rivaroxaban(Mixture of 4 Diastereomers), CAS: 1159977-46-4, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₆S.
3-Morpholinone, CAS: 109-11-5, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇NO₂.
4,5-Dichloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide, CAS: 1770812-37-7, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇Cl₂N₃O₅S.
4-(4-Aminophenyl)-3-morpholinone, CAS: 438056-69-0, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₂O₂.
4-(4-Nitrophenyl)-3-morpholinone, CAS: 446292-04-2, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O₄.
4-[4-[(3-Aminopropyl)amino]phenyl]-3-morpholinone, CAS: 1816946-19-6, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉N₃O₂.
4-[4-[(5R)-5-(Hydroxymethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone, CAS: 117893-60-3, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆N₂O₅.
4-[4-[[(2S)-3-Amino-2-hydroxypropyl]amino]phenyl]-3-morpholinone, CAS: 1403383-56-1, stock: 1.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉N₃O₃.
4-[4-[(5R)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone, CAS: 1411775-06-8, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇N₃O₄.
4-[4-[(5R)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone Hydrochloride, CAS: 1429311-47-6, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀ClN₃O₃.
4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone Hydrochloride, CAS: 898543-06-1, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈ClN₃O₄.
4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone-d4, CAS: 1330169-92-0, stock: 8.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃D₄N₃O₄.
4-[4-[[(2R)-3-Chloro-2-hydroxypropyl]amino]phenyl]-3-morpholinone, CAS: 1252018-10-2, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇ClN₂O₃.
4’-Desmorpholino 4’-[N-(5-chloro-2-carboxy-thienyl)N-(5-Carboxy-3-oxa-pentyl)]amino Rivaroxaban, CAS: 1807455-76-0, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄Cl₂N₄O₆S₂.
5-Chloro-2-thiophenecarboxamide, CAS: 22353-82-8, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄ClNOS.
5-Chloro-2-thiophenecarboxylic Acid, CAS: 24065-33-6, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃ClO₂S.
5-Chloro-N-((2S)-3-chloro-2-hydroxypropyl)thiophene-2-carboxamide, CAS: 1384257-81-1, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉Cl₂NO₂S.
5-Chloro-N-methylthiophene-2-carboxamide, CAS: 97799-98-9, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClNOS.
5-Chloro-N-methylthiophene-2-carboxamide-13C1,d3, CAS: /, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅¹³CH₃D₃ClNOS.
5-Chloro-N-[2-oxo-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-2-thiophenecarboxamide, CAS: 1161719-52-3, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈ClN₃O₄S.
5-chloro-N-[[(5S)-3-[4-[(2-hydroxyethyl)amino]phenyl]-2-oxo-5-oxazolidinyl]methyl]-2-thiophenecarboxamide, CAS: 936232-22-3, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈ClN₃O₄S.
Bis-[Des(5-Chloro-2-carboxythienyl)] Rivaroxaban Phthalamide, CAS: 1365267-36-2, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₃₆N₆O₁₀.
Decarbonyl Rivaroxaban, CAS: 721401-53-2, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀ClN₃O₄S.
Decarbonyl Rivaroxaban-d4, CAS: /, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆D₄ClN₃O₄S.
Dechloro-Rivaroxaban, CAS: 1415566-28-7, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉N₃O₅S.
Dechloro-Rivaroxaban-d4, CAS: /, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₅D₄N₃O₅S.
Des(5-chloro-2-animocarboxythienyl) 4-(3-Oxo-4-morpholinyl) Phenylanimomethyl-2-oxo-3-oxazolidinyl] Rivaroxaban, CAS: /, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₁N₅O₈.
Des(5-chloro-2-carboxythienyl) Methoxycarbonyl Rivaroxaban, CAS: /, stock: 4.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉N₃O₆.
Des-(5-chlorothiophen-2-yl) Rivaroxaban Acetate, CAS: /, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉N₃O₇.
ent-Rivaroxaban, CAS: 865479-71-6, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₅S.
ent-Rivaroxaban-d4, CAS: /, stock: 6.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄D₄ClN₃O₅S.
N,N’-Bis[Des(5-chloro-2-carvoxythienyl) Rivaroxaban] Urea, CAS: 1365267-35-1, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₂N₆O₉.
N-(5-Oxazolidinyl]methyl)-N-(5-chloro-2-thiophenecarbonyl)-4-(3-oxo-4-morpholinyl)aniline, CAS: /, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₅S.
N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-acetamide, CAS: 1429334-00-8, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉N₃O₅.
N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-acetamide-d4, CAS: /, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅D₄N₃O₅.
rac-2-(2-((4-((3-(5-Chlorothiophene-2-carboxamido)-2-hydroxypropyl)amino)phenyl)amino)ethoxy)acetic Acid, CAS: /, stock: 4.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂ClN₃O₅S.
Rivaroxaban, CAS: 366789-02-8, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₅S.
Rivaroxaban Diamide, CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₁Cl₂N₃O₅S₂.
Rivaroxaban Diol(Mixture of Diastereomers), CAS: 1160170-00-2, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀ClN₃O₆S.
Rivaroxaban Hydroxyoxazalone Metabolite(Mixture of Diastereomers), CAS: 1161719-51-2, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₆S.
Rivaroxaban N-Hydrolyse N-5-Chlorothiophene-2-carbaldehyde, CAS: 1151893-81-0, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁Cl₂N₃O₇S₂.
Rivaroxaban Pseudodimer, CAS: 1632463-24-1, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₃₆Cl₂N₆O₁₀S₂.
Rivaroxaban Sulfoxide, CAS: 2197189-38-9, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈ClN₃O₆S.
Rivaroxaban-13C6, CAS: 1261392-59-9, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃¹³C₆H₁₈ClN₃O₅S.
Rivaroxaban-d4, CAS: 1132681-38-9, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄D₄ClN₃O₅S.
(1S,3S)-3-[[(2S)-3-Methyl-2-[[methyl-[[2-(1-methylethyl)thiazol-4-yl]methyl]carbamoyl]amino]-butanoyl]amino]-4-phenyl-1-[(1S)-2-phenyl-1-[[(thiazol-5-ylmethoxy)carbonyl]amino]ethyl]butyl-(2S)-3-methyl-2-[[methyl-[[2-(1-methylethyl)thiazol-4-yl]methyl]carbamoyl]amino]butanoate, CAS: /, stock: 1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₁H₆₉N₉O₇S₃.
(2S)-N-[(1S,2S,4S)-4-Amino-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-3-methyl-2-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]butanamide, CAS: 869368-50-3, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₅N₅O₃S.
(2S,3S,5S)-5-Amino-1,6-diphenyl-2-([[thiazol-5-ylmethoxy)carbonyl]amino]hexan-3-yl 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoate Hydrochloride, CAS: 959315-21-0, stock: 9.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₈N₆O₅S₂•xHCl.
(3S,6S,7S,9S,12S)-7-Hydroxy-N1,N14-dimethyl-3,12-bis(1-methylethyl)-N1,N14-bis[[2-(1-methylethyl)-4-thiazolyl]methyl]-4,11-dioxo-6,9-bis(phenylmethyl)-2,5,10,13-tetraazatetradecanediamide, CAS: 869368-48-9, stock: 9.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₆₆N₈O₅S₂.
(3S,6S,7S,9S,12S)-7-Hydroxy-N1,N14-dimethyl-3,12-bis(1-methylethyl)-N1,N14-bis[[2-(1-methylethyl)-4-thiazolyl]methyl]-4,11-dioxo-6,9-bis(phenylmethyl)-2,5,10,13-tetraazatetradecanediamide-d6, CAS: /, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₆₀D₆N₈O₅S₂.
(S)-(5S,6S,8S)-5,8-Dibenzyl-12,12-dimethyl-3,10-dioxo-1-(thiazol-5-yl)-2,11-dioxa-4,9-diazatridecan-6-yl 2-(3-((2-Isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoate, CAS: /, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₅₆N₆O₇S₂.
1,3-Thiazol-5-ylmethyl N-[(1S)-1-((4S,6S)-4-Benzyl-2-oxo-1,3-oxazinan-6-yl)-2-phenylethyl]carbamate, CAS: 1010809-52-5, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅N₃O₄S.
1,3-Thiazol-5-ylmethyl N-[(1S,2S,4S)-4-(acetylamino)-1-benzyl-2-hydroxy-5-phenylpentyl]carbamate, CAS: 1010808-43-1, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉N₃O₄S.
2-Chloro-5-(chloromethyl)thiazole, CAS: 105827-91-6, stock: 2.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃Cl₂NS.
2-Desisopropyl-2-ethyl Ritonavir, CAS: 165315-26-4, stock: 1.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₆N₆O₅S₂.
(2S)-3,4-Dihydro-2H-1-benzopyran-2-carbonyl Chloride, CAS: 130049-78-4, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉ClO₂.
2-Hydroxy-2-methylpropanethioamide, CAS: 1051463-20-7, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NOS.
(2S)-Chroman-2-carboxylic Acid, CAS: 83780-46-5, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀O₃.
(E)-1-Acetyl-α-(5-fluoro-2-hydroxyphenyl)-N-hydroxy-4-piperidinemethanimine, CAS: 84162-97-0, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇FN₂O₃.
2S,3S,5S-2-Amino-5-[N-[[(5-thiozolyl)methoxy]carbonyl]amino]-1,6-diphenyl-3-hydroxyhexane, CAS: 144164-10-3, stock: 2.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇N₃O₃S.
2S,3S,5S-5-Amino-2-[N-[[(5-thiozolyl)methoxy]carbonyl]amino]-1,6-diphenyl-3-hydroxyhexane, CAS: 144164-11-4, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇N₃O₃S.
(E)-1-Acetyl-N-(acetyloxy)-α-(5-fluoro-2-hydroxyphenyl)-4-piperidinemethanimine, CAS: 84163-52-0, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉FN₂O₄.
(E)-4-(2,4-Difluorobenzoyl)piperidine Oxime, CAS: 691007-07-5, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄F₂N₂O.
4-Dehydroxy-5-hydroxy Ritonavir, CAS: 202816-62-4, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₈N₆O₅S₂.
4-epi-Ritonavir, CAS: 1414933-81-5, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₈N₆O₅S₂.
4-epi-Ritonavir-d6, CAS: /, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₂D₆N₆O₅S₂.
4-Hydroxy-13,13-dimethyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl) 12-Oxa-2,7,10-triazatetradecanoic Acid 5-Thiazolylmethyl Ester, CAS: 165315-96-8, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₄N₄O₆S.
(S)-(R)-9-Hydroxy Risperidone-(O-chroman-2-carboxylate)-d4, CAS: /, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₁D₄FN₄O₅.
4S-4-Dibenzylamino-3-oxo-5-phenylpentanonitrile, CAS: 156732-12-6, stock: 6.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄N₂O.
5S-2-Amino-5-dibenzylamino-4-oxo-1,6-diphenylhex-2-ene, CAS: 156732-13-7, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₂N₂O.
(S)-9-Hydroxy Risperidone-(O-chroman-2-carboxylate)-d4, CAS: /, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₁D₄FN₄O₅.
(Z)-4-(2,4-Difluorobenzoyl)piperidine Oxime, CAS: 691007-05-3, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄F₂N₂O.
1,4-Piperidinedicarboxylic Acid 1-Ethyl Ester, CAS: 118133-15-6, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₅NO₄.
1-[4-(5-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]-ethanone, CAS: 84162-84-5, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆FNO₃.
2,4-Difluorobenzoyl Risperidone Impurity, CAS: 158697-67-7, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇F₂N₃O₂.
Bis(thiazol-5-yl-methyl)[carbonylbis[imino[(2S,3S,5S)-3-hydroxy-1,6-diphenylhexane-5,2-diyl]]]dicarbamate, CAS: /, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₇H₅₂N₆O₇S₂.
2,4-Difluorophenyl 4-Piperidinyl Ketoxime, CAS: 84163-46-2, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄F₂N₂O.
Bis(thiazol-5-ylmethyl) ((2S,2’S,3S,3’S,5S,5’S)-(Carbonylbis(azanediyl))bis(3-((tert-butyldimethylsilyl)oxy)-1,6-diphenylhexane-5,2-diyl))dicarbamate, CAS: /, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₉H₈₀N₆O₇S₂Si₂.
3-(2-Chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 41078-70-0, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁ClN₂O.
3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 63234-80-0, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅ClN₂O.
Dehydroritonavir, CAS: 1156504-13-0, stock: 6.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₆N₆O₅S₂.
3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one N-Oxide, CAS: 1797131-18-0, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅ClN₂O2.
3-(2-Chloroethyl-d4)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 1189465-23-3, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇D₄ClN₂O.
3-(2-Chloroethyl-d4)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 1189712-26-2, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁D₄ClN₂O.
3-(2-Chloroethyl-d4)-2-methyl-9-(phenylmethoxy)-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 1184973-69-0, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₃D₄ClN₂O₂.
Des(isopropylthiazolyl) Ritonavir, CAS: 176655-57-5, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₉N₅O₅S.
Des(isopropylthiazolyl)-N-methyl Ritonavir, CAS: 959351-57-6, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₄₁N₅O₅S.
3-(2-Ethoxyethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: /, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀N₂O₂.
3-(2-Hydroxyethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 66698-27-9, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₂O₂.
Des(isopropylthiazolyl)-N-methyl Ritonavir-d6, CAS: /, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₅D₆N₅O₅S.
Desthiazolylmethyl Ritonavir, CAS: 256328-82-2, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₃N₅O₄S.
3-(2-Methoxyethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: /, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈N₂O₂.
3-Ethyl-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 16867-31-5, stock: 7.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂N₂O.
Desthiazolylmethyloxycarbonyl Ritonavir, CAS: 176655-55-3, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₅N₅O₃S.
Desthiazolylmethyloxycarbonyl Ritonavir-d6, CAS: 1217772-02-5, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₉D₆N₅O₃S.
3-Ethyl-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one(Risperidone Impurity), CAS: 70381-58-7, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₂O.
3-Vinyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 832747-59-8, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O.
ent-Ritonavir, CAS: /, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₈N₆O₅S₂.
ent-Ritonavir Isopropyl-D6, CAS: /, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₂D₆N₆O₅S₂.
3-[2-[4-(2-Fluoro-4-hydroxybenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 1391053-32-9, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈FN₃O₃.
3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one Hydrochloride, CAS: /, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉ClFN₃O₃.
Hydroxy Ritonavir, CAS: 176655-56-4, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₈N₆O₆S₂.
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-7-methoxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 130049-83-1, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉FN₄O₃.
3-[2-[4-(6-Fluoro-2-benzoxazolyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (Risperidone Impurity), CAS: 1005191-81-0, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇FN₄O₂.
Hydroxy Ritonavir-d3, CAS: /, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₅D₃N₆O₆S₂.
3-[2-[4-[(4-Fluoro-2-hydroxyphenyl)(hydroxyimino)methyl]-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one;, CAS: 1391062-47-7, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉FN₄O₃.
3-[2-[4-[(Z)-(4-Fluoro-2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)phenyl](hydroxyimino)methyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one(Risperidone Impurity, Mixture of E/Z isomers), CAS: 1346606-24-3, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₄₀F₂N₆O₃.
3-[2-[4-[4-Fluoro-2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]benzolyl]piperidin-1-yl]ethyl-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one, CAS: 1329796-66-8, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₉F₂N₅O₃.
4-(2,4-Difluorobenzoyl)piperidine Hydrochloride, CAS: 106266-04-0, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄ClF₂NO.
5-Fluoro Risperidone, CAS: 1199589-74-6, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇FN₄O₂.
5-Fluoro Risperidone-d4, CAS: 1346598-47-7, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₃D₄FN₄O₂.
N-(4-Nitrophenoxycarbonyl)-L-valine Methyl Ester, CAS: 162537-10-2, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆N₂O₆.
6,7,8,9-Tetrahydro-3-(2-iodoethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one-d4, CAS: /, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁D₄IN₂O.
N-De-4-ethyl-2-isopropylthiazole Ritonavir N-(Thiazol-5-ylmethyl ((2S,3S)-3-Hydroxy-1,6-diphenylhexan-2-yl)carbamate), CAS: /, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₆₁N₇O₈S₂.
6-Desfluoro-6-hydroxy Risperidone, CAS: 106266-11-9, stock: 8.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈N₄O₃.
6-Desfluoro-6-methoxy Risperidone, CAS: 1246817-15-1, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀N₄O₃.
N-[(1S,2S,4S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic Acid 5-Thiazolylmethyl Ester, CAS: 162849-95-8, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₅N₃O₅S.
N-[[N-Methyl-N-[(2-isopropyl-1,1,1,3,3,3-d6]-4-thiazolyl)methyl)amino]carbonyl-L-valine Carboxylic Acid, CAS: 1331906-73-0, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇D₆N₃O₃S.
N-[[N-Methyl-N-[(2-isopropyl-1,1,1,3,3,3-d6]-4-thiazolyl)methyl)amino]carbonyl-L-valine Methyl Ester, CAS: 1331897-89-2, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉D₆N₃O₃S.
6-Methyl Risperidone, CAS: 1346602-28-5, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉FN₄O₂.
N-[[N-Methyl-N-[(2-isopropyl]-4-thiazolyl)methyl)amino]carbonyl-L-valine Carboxylic Acid, CAS: 154212-61-0, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃N₃O₃S.
N-[[N-Methyl-N-[(2-isopropyl]-4-thiazolyl)methyl)amino]carbonyl-L-valine Carboxylic Acid Isobutyl Alcohol Ester, CAS: /, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₁N₃O₃S.
7-Hydroxy Risperidone, CAS: 147663-04-5, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇FN₄O₃.
7-Hydroxy Risperidone-d4, CAS: 1215454-04-8, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₃D₄FN₄O₃.
N-[[N-Methyl-N-[(2-isopropyl]-4-thiazolyl)methyl)amino]carbonyl-L-valine Carboxylic Acid Isobutyl Alcohol Ester-d7, CAS: /, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄D₇N₃O₃S.
N-[[N-Methyl-N-[(2-isopropyl]-4-thiazolyl)methyl)amino]carbonyl-L-valine Methyl Ester, CAS: 154248-99-4, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅N₃O₃S.
9-Keto Risperidone (90%), CAS: 1189516-65-1, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅FN₄O₃.
Ritonavir, CAS: 155213-67-5, stock: 4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₈N₆O₅S₂.
Desfluoro Risperidone, CAS: 106266-09-5, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈N₄O₂.
Ethyl 4-(Chlorocarbonyl)-1-piperidinecarboxylate, CAS: 146801-00-5, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄ClNO₃.
Ritonavir Hydroperoxide, CAS: 2034136-66-6, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₈N₆O₇S₂.
Ritonavir Impurity K, CAS: /, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₅N₃O₅S.
Methyl 5,6,7,8-Tetradehydro Risperidone, CAS: 106266-08-4, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅FN₄O₂.
Ritonavir O-β-D-Glucuronide, CAS: 190649-36-6, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₅₆N₆O₁₁S₂.
Ritonavir O-Sulfate, CAS: /, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₈N₆O₈S₃.
Ritonavir Valine, CAS: /, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₅₇N₇O₆S₂.
Ritonavir-13C3, CAS: 1217673-23-8, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄¹³C₃H₄₈N₆O₅S₂.
Ritonavir-d6, CAS: 1217720-20-1, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₂D₆N₆O₅S₂.
tert-Butyl ((2S,4S,5S)-4-Hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate, CAS: 869368-49-0, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₅₃N₅O₅S.
Thiazol-5-ylmethyl ((2S,3S,5S)-5-Amino-3-((tert-butyldimethylsilyl)oxy)-1,6-diphenylhexan-2-yl)carbamate, CAS: /, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₁N₃O₃SSi.
Tipranavir β-D-Glucuronide, CAS: 947408-14-2, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₁F₃N₂O₁₁S.
Tipranavir-d4 β-D-Glucuronide, CAS: /, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₃₇D₄F₃N₂O₁₁S.
[4-[(2-Amino-3-methyl-1-oxobutyl)amino]-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-carbamic Acid 5-Thiazolylmethyl Ester, CAS: 765875-58-9, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₆N₄O₄S.
Risperidone (R)-9-O-[(2S)-Chroman-2-one], CAS: /, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₅FN₄O₅.
Risperidone (R)-9-O-[(2S)-Chroman-2-one] Mixture, CAS: /, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₅FN₄O₅.
Risperidone (R)-9-O-[(2S)-Chroman-2-one]-d4, CAS: /, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₁D₄FN₄O₅.
Risperidone 9-(2-Hydroxyacetic Acid), CAS: /, stock: 6.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉FN₄O₅.
Risperidone 9-Ethylidenecarboxylate, CAS: /, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇FN₄O₄.
Risperidone 9-Ethylidenecarboxylate Hydrochloride, CAS: /, stock: 7.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇FN₄O₄.
Risperidone Carboxylate Impurity, CAS: 1346603-86-8, stock: 3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇FN₄O₂.
Risperidone E-Oxime Impurity, CAS: 691007-09-7, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈F₂N₄O₂.
Risperidone N-Oxide, CAS: 832747-55-4, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇FN₄O₃.
Risperidone Pyrimidinone-N-oxide(Risperidone impurity), CAS: 1301724-91-3, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇FN₄O₃.
Risperidone Z-Oxime Impurity, CAS: 132961-05-8, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈F₂N₄O₂.
Risperidone-d4, CAS: 1020719-76-9, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₃D₄FN₄O₂.
1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide Hydrochloride, CAS: 256499-19-1, stock: 5.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃ClFN₅.
2-Desfluoro-3-fluoro-riociguat, CAS: /, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉FN₈O₂.
2-Desfluoro-4-fluoro-riociguat, CAS: /, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉FN₈O₂.
2-Desfluoro-riociguat, CAS: /, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀N₈O₂.
2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidine-4,5,6-triamine, CAS: 428854-24-4, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅FN₈.
2-[1-[(2-Fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-N5-methyl-4,5,6-pyrimidinetriamine, CAS: 1702271-98-4, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇FN₈.
6-Amino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-7,9-dihydro-8H-purin-8-one, CAS: 1361569-10-9, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₃FN₈O.
Dimethyl (6-Amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidine-4,5-diyl)dicarbamate, CAS: /, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉FN₈O₄.
Methyl (4-Amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-6-((methoxycarbonyl)amino)pyrimidin-5-yl)(methyl)carbamate, CAS: /, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₁FN₈O₄.
Methyl (4-Amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-6-(methylamino)pyrimidin-5-yl)carbamate, CAS: /, stock: 4.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉FN₈O₂.
Methyl-dihydropurinone, CAS: 1361569-18-7, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₅FN₈O.
N-Desmethyl Riociguat, CAS: 625115-52-8, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇FN₈O₂.
N-Desmethyl Riociguat-d3, CAS: /, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄D₃FN₈O₂.
N-Desmethylriociguat N-Glucuronide, CAS: /, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₅FN₈O₈.
N-Methyl Riociguat, CAS: /, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁FN₈O₂.
Riociguat, CAS: 625115-55-1, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉FN₈O₂.
Riociguat-d3, CAS: 1304478-72-5, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₆D₃FN₈O₂.
Riociguat-d6, CAS: 1304478-43-0, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₃D₆FN₈O₂.
1-Aminopiperidine Hydrochloride, CAS: 63234-70-8, stock: 5.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₃ClN₂.
1-Aminopiperidine-d10 Hydrochloride, CAS: /, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃D₁₀N₂.
5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic Acid, CAS: 162758-35-2, stock: 8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₁Cl₃N₂O₂.
5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic Acid-13C,d7, CAS: /, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆¹³CH₄D₇Cl₃N₂O₂.
Rimonabant Hydrochloride, CAS: 158681-13-1, stock: 1.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂Cl₄N₄O.
Rimonabant-d10 Hydrochloride, CAS: 1044909-61-6, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₂D₁₀Cl₄N₄O.
2-Amino-5-(trifluoromethoxy)phenyl Thiocyanate, CAS: 1391054-04-8, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅F₃N₂S.
2-Amino-6-(tert-butyl)benzothiazole, CAS: 131395-10-3, stock: 2.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂S.
4-(1,1,2,2-Tetrafluoroethoxy)aniline, CAS: 713-62-2, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇F₄NO.
4-(Trifluoromethoxy)aniline, CAS: 461-82-5, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆F₃NO.
4-(Trifluoromethoxy)aniline-15N, CAS: 1246815-55-3, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆F₃¹⁵NO.
4-Bromo Riluzole, CAS: 144631-82-3, stock: 6.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄BrF₃N₂OS.
N-Hydroxy Riluzole, CAS: 179070-90-7, stock: 2.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅F₃N₂O₂S.
N-Hydroxy Riluzole N-β-D-Glucuronide, CAS: 179070-90-7, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃F₃N₂O₈S.
N-Hydroxy Riluzole O-β-D-Glucuronide, CAS: 1394929-56-6, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃F₃N₂O₈S.
N-Hydroxy Riluzole O-β-D-Glucuronide-13C,15N2, CAS: /, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃¹³CH₁₃F₃¹⁵N₂O₈S.
N-Hydroxy Riluzole-13C,15N2, CAS: 1189887-96-4, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇¹³CH₅F₃¹⁵N₂O₂S.
N-[6-(Trifluoromethoxy)-2-benzothiazolyl]urea, CAS: 1456696-94-8, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆F₃N₃O₂S.
N-[6-(Trifluoromethoxy)-2-benzothiazolyl]urea-13C,15N2, CAS: /, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³CH₆F₃N¹⁵N₂O₂S.
Riluzole, CAS: 1744-22-5, stock: 9.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅F₃N₂OS.
Riluzole 4-Trifluoromethoxy Isomer, CAS: 235101-36-7, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅F₃N₂OS.
Riluzole 5-Trifluoromethoxy Isomer, CAS: 752969-85-0, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅F₃N₂OS.
Riluzole Hydrochloride, CAS: 850608-87-6, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅F₃N₂OS • (HCl).
Riluzole N-β-D-Glucuronide, CAS: /, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃F₃N₂O₇S.
Riluzole-13C,15N2, CAS: 1215552-03-6, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇¹³CH₅F₃¹⁵N₂OS.
2-Amino-4-methylpyridine, CAS: 695-34-1, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₂.
(1Z)-Rilpivirine, CAS: 500287-94-5, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈N₆.
(2S,3R,4R,5S)-6-((2-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)amino)-5-((E)-2-cyanovinyl)-3-(hydroxymethyl)benzyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid, CAS: /, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₆N₆O₈.
(2S,3R,4R,5S)-6-((2-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)amino)-5-((E)-2-cyanovinyl)-3-methylbenzyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid, CAS: /, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₆N₆O₇.
(E)-3-(4-Amino-3,5-bis(methoxymethyl)phenyl)acrylonitrile, CAS: /, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆N₂O₂.
1,3-Bis(methoxymethyl)-2-nitrobenzene, CAS: /, stock: 9.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₄.
2,6-Bis(methoxymethyl)aniline, CAS: /, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅NO₂.
2,6-Dihydroxymethyl Rilpivirine, CAS: /, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈N₆O₂.
2-Amino-5-iodo-3-methylbenzenemethanol, CAS: 108857-25-6, stock: 5.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀INO.
2-Hydroxymethyl Rilpivirine, CAS: 1798429-64-7, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈N₆O.
2-Nitro-1,3-benzenedimethanol, CAS: 16578-60-2, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NO₄.
3-(4-Amino-3,5-diethylphenyl)-2-propenenitrile, CAS: 885453-58-7, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂N₂O.
3-(4-Amino-3-(methoxymethyl)-5-methylphenyl)acrylonitrile Hydrochloride, CAS: /, stock: 1.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅ClN₂O.
4-Amino-N-cyanobenzimidamide, CAS: /, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈N₄.
4-Iodo-2,6-bis(methoxymethyl)aniline, CAS: /, stock: 8.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄INO₂.
Bis-boc Rilpivirine, CAS: /, stock: 9.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₄N₆O₄.
Despropenenitrile Bromo Rilpivirine, CAS: 374067-85-3, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆BrN₅.
Rilpivirine, CAS: 500287-72-9, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈N₆.
Rilpivirine N1-Oxide, CAS: /, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈N₆O.
Rilpivirine-d6, CAS: 1312424-26-2, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₂D₆N₆.
11-Desmethyl Rifaximin, CAS: /, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₄₉N₃O₁₁.
11-Desmethyl Rifaximin-d4, CAS: 1316302-12-1, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₄₅D₄N₃O₁₁.
25-Desacetyl Rifapentin, CAS: 79039-56-8, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₆₂N₄O₁₁.
3-Amino-4-deoxy-4-imino Rifamycin S, CAS: 62041-01-4, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₇N₃O₁₁.
3-Aminorifamycin S, CAS: 51756-80-0, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₆N₂O₁₂.
3-Azido-1,4-dideoxy-1,4-dihydro-1,4-dioxorifamycin, CAS: 59886-91-8, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₄N₄O₁₂.
3-Bromorifamycin S (>90%), CAS: 57375-25-4, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₄BrNO₁₂.
Rifalazil, CAS: 129791-92-0, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₁H₆₄N₄O₁₃.
Rifamdin, CAS: 89499-17-2, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₆₄N₄O₁₂.
Rifamdin-d4, CAS: /, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₆₀D₄N₄O₁₂.
Rifamdin-d9, CAS: /, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₅₅D₉N₄O₁₂.
Rifamycin B, CAS: 13929-35-6, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₄₉NO₁₄.
Rifamycin O, CAS: 14487-05-9, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₄₇NO₁₄.
Rifamycin S, CAS: 13553-79-2, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₅NO₁₂.
Rifamycin SV Sodium, CAS: 14897-39-3, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₆NNaO₁₂.
Rifaximin, CAS: 80621-81-4, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₅₁N₃O₁₁.
Rifaximin-d6 (Major), CAS: 1262992-43-7, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₄₅D₆N₃O₁₁.
Rifogal, CAS: 6998-60-3, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₄₇NO₁₂.
Nor Securinine, CAS: 2650-35-3, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃NO₂.
Phyllanthine, CAS: 20072-02-0, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇NO₃.
Phyllanthine-d3, CAS: /, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄D₃NO₃.
Securinine, CAS: 5610-40-2, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅NO₂.
1-Cyclopentylethanone, CAS: 6004-60-0, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₂O.
1-Cyclopentylethanone-d4(Also see C988477), CAS: /, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈D₄O.
1-Cyclopentylethanone-d4, CAS: /, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈D₄O.
25-Deacetyl-21-acetyl Rifampicin, CAS: 1416773-22-2, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₅₈N₄O₁₂.
25-Deacetyl-23-acetyl Rifampicin, CAS: 1416773-23-3, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₅₈N₄O₁₂.
25-Desacetyl Rifampicin, CAS: 16783-99-6, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₅₆N₄O₁₁.
25-Desacetyl Rifampicin-d3, CAS: /, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₅₃D₃N₄O₁₁.
3-Formyl Rifamycin, CAS: 13292-22-3, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₇NO₁₃.
3-[(4-Methyl-1-piperazinyllimino)methyl] Rifamycin O, CAS: /, stock: 7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₅₈N₄O₁₄.
N,N-Bis(hydroxymethyl)tert-butylamine, CAS: 55686-22-1, stock: 1.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₅NO₂.
N-Demethyl Rifampicin, CAS: 13292-45-0, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₅₆N₄O₁₂.
N-Demethyl Rifampicin-d8, CAS: /, stock: 3.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₄₈D₈N₄O₁₂.
N-Methyl Rifampicin, CAS: /, stock: 9.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₆₂N₄O₁₂.
Rifampicin, CAS: 13292-46-1, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₅₈N₄O₁₂.
Rifampicin N-4’-Oxide, CAS: 125833-03-6, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₅₈N₄O₁₃.
Rifampicin-d3, CAS: 1262052-36-7, stock: 5.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₅₅D₃N₄O₁₂.
Rifapentine, CAS: 61379-65-5, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₇H₆₄N₄O₁₂.
23-Monoketo Rifabutin, CAS: /, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₅₈N₄O₁₁.
23-Oxo Rifabutin, CAS: /, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₆₀N₄O₁₁.
25-O-Deacetyl Rifabutin, CAS: 100324-63-8, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₆₀N₄O₁₀.
25-O-Deacetyl Rifabutin-d7, CAS: /, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₅₃D₇N₄O₁₀.
25-O-Deacetyl-23-O-acetyl Rifabutin, CAS: 1242076-43-2, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₆₂N₄O₁₁.
8-Isobutyl-1,4-dioxa-8-azaspiro[4.5]decane-d7, CAS: /, stock: 8.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄D₇NO₂.
N-Desisobutyl-N-propyl Rifabutin, CAS: 75903-10-5, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₆₀N₄O₁₁.
Rifabutin, CAS: 72559-06-9, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₆₂N₄O₁₁.
Rifabutin-d7, CAS: /, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₅₆D₇N₄O₁₁.
(-)-Riboflavin, CAS: 83-88-5, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀N₄O₆.
1-Deazariboflavin, CAS: 64183-66-0, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁N₃O₆.
1-Deoxy-1-[(3,4-dimethylphenyl)(1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinyl)amino]-D-ribitol 2,3,4,5-Tetraacetate, CAS: 59389-71-8, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁N₃O₁₀.
1-Deoxy-1-[(3,4-dimethylphenyl)amino]-D-ribitol, CAS: 3051-94-3, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁NO₄.
1-Deoxy-1-[(3-hydroxymethyl-4-methyl-6-(2-phenyldiazenyl)phenyl)amino]-D-ribitol, CAS: /, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅N₃O₅.
1-Deoxy-1-[(3-hydroxymethyl-4-methylphenyl)amino]-D-ribitol, CAS: /, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₁NO₅.
10-(((4R,5R,6S)-6-(((tert-Butyldiphenylsilyl)oxy)methyl)-5-hydroxy-2,2-dimethyl-1,3-dioxan-4-yl)methyl)-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione, CAS: /, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₂N₄O₆Si.
10-[3-(2,2-Diimethyl-1,3-dioxolan-4-yl)-2,3-dihydroxypropyl]-7,8-dimethyl-isoalloxazine, CAS: 22854-81-5, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄N₄O₆.
2,3,4,5-Tetra-O-acetyl 5-Deazariboflavin, CAS: 59389-72-9, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉N₃O₁₀.
2’,4’-O-Phenylmethylene Di-[O,O’-(Dibenzyl Phosphonate)]-riboflavin, CAS: /, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₅₀N₄O₁₂P₂.
2’,4’-O-Phenylmethylene-O-(tert-butyldiphenylsilyl)-riboflavin, CAS: /, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₄₂N₄O₆Si.
2’,4’-O-Phenylmethylene-riboflavin, CAS: /, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄N₄O₆.
3,4-Xylyl-6-phenylazo-D-ribitylamine, CAS: 21037-26-3, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅N₃O₄.
4-Hydroxyquinoline, CAS: 611-36-9, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO.
5-Amino-2-methylbenzenemethanol, CAS: 111437-10-6, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
5-Deazariboflavin, CAS: 19342-73-5, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁N₃O₆.
6-Methylguanamine, CAS: 542-02-9, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇N₅.
8-Hydroxymethyl Riboflavin, CAS: /, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀N₄O₇.
D-Oxime Ribose, CAS: 6272-50-0, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₁NO₅.
Lumichrome, CAS: 1086-80-2, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₄O₂.
Lumichrome-d8, CAS: /, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂D₈N₄O₂.
Lumiflavin-3-acetic Acid, CAS: 20227-26-3, stock: 6.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄N₄O₄.
Lumiflavin-3-acetic Acid Ethyl Ester, CAS: 74178-39-5, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₄O₄.
N6-(2-Aminoethyl)-FAD, CAS: 167962-39-2, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₈N₁₀O₁₅P₂.
Riboflavin 3’,4’-Diphosphate, CAS: 86108-27-2, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂N₄O₁₂P₂.
Riboflavin 3’,5’-Diphosphate, CAS: 86108-26-1, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂N₄O₁₂P₂.
Riboflavin 4’,5’-Diphosphate, CAS: 86108-25-0, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂N₄O₁₂P₂.
Riboflavin 5’-(Dihydrogen Phosphate) Monosodium Salt Dihydrate (>80%), CAS: 6184-17-4, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀NaN₄O₉P•2[H₂O].
Riboflavin Phosphate Sodium Salt (~70%), CAS: 130-40-5, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀N₄NaO₉P.
Riboflavin-13C,15N2, CAS: /, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆¹³CH₂₀N₂¹⁵N₂O₆.
Riboflavin-3’-phosphate, CAS: 80400-93-7, stock: 5.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁N₄O₉P.
Riboflavin-4’-phosphate, CAS: 60697-29-2, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁N₄O₉P.
Riboflavine 8-Methyl-d3, CAS: /, stock: 8.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇D₃N₄O₆.
Riboflavine Tetrabutyrate, CAS: 752-56-7, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₄N₄O₁₀.
Roseoflavin, CAS: 51093-55-1, stock: 7.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃N₅O₆.
Trioctylammonium Phosphate Riboflavin, CAS: /, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₇₁N₅O₉P⁺.
Vitamin B2 (Riboflavin) (13C4, 99%; 15N2, 98%), CAS: 1217461-14-7, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃¹³C₄H₂₀N₂¹⁵N₂O₆.
(3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-methylethoxy)-1-Cyclohexene-1-carboxylic Acid Ethyl Ester, CAS: 1052063-36-1, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄N₂O₄.
1,2,4-Triazole-3-carboxylic Acid, CAS: 4928-87-4, stock: 2.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₃N₃O₂.
1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane, CAS: 69304-37-6, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₈Cl₂OSi₂.
1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxylic Acid Methyl Ester(Ribavirin Impurity H), CAS: 38934-69-9, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃N₃O₆.
1-[2,3-O-Isopropylidene-β-D-ribofuranosyl]-1,2,4-triazole-3-carboxylic Acid Methyl Ester, CAS: 594860-43-2, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇N₃O₆.
1-[2-Deoxy-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-erythro-pentofuranosyl]-1H-1,2,4-triazole-3-carboxamide, CAS: 359861-06-6, stock: 1.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₈N₄O₅Si₂.
1-[2-O-(Phenoxythioxomethyl)-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-ribofuranosyl]-1H-1,2,4-triazole-3-carboxamide, CAS: 359861-00-0, stock: 6.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₂N₄O₇SSi₂.
2’,3’-Isopropylidene α-Ribavirin, CAS: 69313-80-0, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₄O₅.
2’,3’-Isopropylidene Ribavirin, CAS: 52663-90-8, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₄O₅.
2’,3’-O-Isopropylidene-1-α-D-ribofuranosyl-1,2,4-triazole-3-carboxylic Acid Methyl Ester 5’-O-Acetate, CAS: /, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₃O₇.
2’,3’-O-Isopropylidene-1-α/β-D-ribofuranosyl-1,2,4-triazole-3-carboxylic Acid Methyl Ester 5’-O-Acetate, CAS: /, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₃O₇.
2’,3’-O-Isopropylidene-1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxylic Acid Methyl Ester 5’-O-Acetate, CAS: /, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₃O₇.
2’,3’-O-Isopropylidene-1-β-D-ribofuranosyl-1,2,4-triazole-5-carboxylic Acid Methyl Ester 5’-O-Acetate, CAS: /, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₃O₇.
2’-Deoxyribavirin, CAS: 40372-06-3, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₄.
2’-Deoxyribavirin-5’-triphosphate Triethylamine Salt, CAS: /, stock: 9.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅N₄O₁₃P₃•x(Et₃N).
5’-O-Acetyl Ribavirin, CAS: 58151-87-4, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₄O₆.
5’-O-Benzoyl Ribavirin, CAS: 58151-90-9, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆N₄O₆.
Iso Ribavirin (Ribavirin Impurity G), CAS: 39030-43-8, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₅.
α-Ribavirin (Ribavirin Impurity B), CAS: 57198-02-4, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₅.
Levovirin, CAS: 206269-27-4, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₅.
Levovirin -13C5, CAS: /, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₅H₁₂N₄O₅.
Methyl 1,2,4-Triazole-3-carboxylate, CAS: 4928-88-5, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₃O₂.
Methyl 1,2,4-Triazole-3-carboxylate-13C2, CAS: /, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂¹³C₂H₅N₃O₂.
Ribavirin 5’-Monophosphate Dilithium Salt (90%), CAS: 66983-94-6, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁Li₂N₄O₈P.
Ribavirin Carboxylic Acid, CAS: 39925-19-4, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁N₃O₆.
Viramidine Hydrochloride, CAS: 40372-00-7, stock: 9.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄ClN₅O₄.
Viramidine-13C5 Hydrochloride, CAS: /, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₅H₁₄ClN₅O₄.
Revaprazan Hydrochloride, CAS: 178307-42-1, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄ClFN₄.
Revaprazan-d3 Hydrochloride, CAS: 1346602-51-4, stock: 3.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₁D₃ClFN₄.
1-Acetoxy-1,3-butadiene, CAS: 1515-76-0, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈O₂.
Rhein 8-β-D-Glucuronide, CAS: 70793-10-1, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆O₁₂.
Rhein Methylate 2,3,4,6-Tetraacetate β-D-Glucopyranose, CAS: /, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₈O₁₅.
Rhein Methylate 3-(2,3,4,6-Tetraacetate β-D-Glucopyranose), CAS: /, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₈O₁₅.
Rheinanthrone, CAS: 480-09-1, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
11-cis-Retinol, >85%, CAS: 22737-96-8, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O.
13-cis-3-Dehydroretinol, CAS: 90694-28-3, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O.
13-cis-Retinol, CAS: 2052-63-3, stock: 4.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O.
13-cis-Retinyl Acetate (85%), CAS: 34356-31-5, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₂.
13-cis-Vitamin A Palmitate, CAS: 26771-20-0, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₆₀O₂.
3-Dehydro Retinol, CAS: 79-80-1, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O.
3-Dehydro Retinol Acetate, CAS: 20008-04-2, stock: 8.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₀O₂.
3-Dehydro Retinol Acetate-d3, CAS: 1795137-64-2, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇D₃O₂.
3-Hydroxyl-retinol, CAS: 6890-93-3, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₂.
3-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-2-propenoic Acid Ethyl Ester, CAS: 917877-01-1, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆O₄.
4,5-Didehydro-5,6-dihydro-retinol 15-Hexadecanoate, CAS: 1976029-78-3, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₆₀O₂.
4-Keto Retinol (~90%), CAS: 62702-55-0, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₂.
9-cis,13-cis-Retinol (70%), CAS: 29444-25-5, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O.
9-cis,13-cis-Retinol 15-Acetate, CAS: 29444-27-7, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₂.
9-cis,13-cis-Retinol 15-Acetate-d5, CAS: 1217219-62-9, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇D₃O₂.
9-cis,13-cis-Retinol-d5, CAS: /, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅D₅O.
9-cis-4-Ketoretinol, CAS: 1076198-35-0, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₂.
9-cis-5,6-Epoxy Retinol Acetate, CAS: /, stock: 3.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₃.
9-cis-5,6-Epoxy Retinol Acetate-D5, CAS: /, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇D₅O₃.
9-cis-Retinol, CAS: 22737-97-9, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O.
9-cis-Retinol Acetate-d5, CAS: /, stock: 9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇D₅O₂.
9-cis-Retinol-d5, CAS: /, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅D₅O.
all-trans-13,14-Dihdyro Retinol, CAS: 115797-14-3, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O.
all-trans-Anhydro Retinol (90%), CAS: 1224-78-8, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈.
all-trans-Retinol, CAS: 68-26-8, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O.
all-trans-Retinol-d5, >80%, CAS: 1185244-58-9, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅D₅O.
all-trans-Retinyl Oleate, CAS: 631-88-9, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₆₂O₂.
all-trans-Retinyl Palmitate, CAS: 79-81-2, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₆₀O₂.
all-trans-Retinyl Palmitate-d5 (Major), CAS: 1331666-45-5, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₅₅D₅O₂.
all-trans-Retinyl Stearate, CAS: 631-87-8, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₆₄O₂.
Bovine LRAT (Lecithin retinol acyltransferase) ELISA Kit (96T), CAS: /, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Ethyl 2-Chloro-5-methylthiazole-4-carboxylate, CAS: 907545-27-1, stock: 1.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈NO₂SCl.
Human RBP1(Retinol-binding protein 1) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human RBP3(Retinol Binding Protein 3, Interstitial) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human RBP4(Retinol-binding protein 4) ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human SDR16C5 (Epidermal retinol dehydrogenase 2) ELISA Kit (96T), CAS: /, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Kitol Diacetate(Mixture of Diastereomers), CAS: 13828-13-2, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄Hg₄O₄.
Kitol, 90%(Mixture of Diastereomers), CAS: 22555-09-5, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₆₀O₂.
Mouse Lrat (Lecithin retinol acyltransferase) ELISA Kit (96T), CAS: /, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse RBP1(Retinol-binding protein 1) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse RBP4(Retinol Binding Protein 4, Plasma) ELISA Kit (96T), CAS: /, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Sdr16c5 (Epidermal retinol dehydrogenase 2) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
rac all-trans 4-(Acetyloxy) Retinol Acetate, CAS: /, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₄O₄.
rac all-trans 4-(Acetyloxy) Retinol Acetate-d4, CAS: /, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀D₄O₄.
rac all-trans 3-(Acetyloxy) Retinol-d5 Acetate, CAS: 1346606-58-3, stock: 7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉D₅O₄.
Rat Lrat (Lecithin retinol acyltransferase) ELISA Kit (96T), CAS: /, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Rbp1(Retinol-binding protein 1) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Rbp4(Retinol-binding protein 4) ELISA Kit (96T), CAS: /, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Retinyl Palmitate-d31, CAS: /, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₂₉D₃₁O₂.
Retinyl Propionate (Stabilized with BHT) 90%, CAS: 7069-42-3, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄O₂.
Retinyl Propionate-d3, CAS: 1795139-60-4, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₁D₃O₂.
Stearyl Glycyrrhetinate, CAS: 13832-70-7, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₈H₈₂O₄.
Vitamin A Acetate, CAS: 127-47-9, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₂.
2-Amino-4-[(4-fluorobenzyl)amino]-1-nitrobenzene, CAS: 1263404-74-5, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂FN₃O₂.
4-(4-Fluorobenzylamino)-1,2-phenylenediamine, CAS: 491871-67-1, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄FN₃.
N-Acetyl Retigabine, CAS: 229970-68-7, stock: 2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆FN₃O.
N4-[(4-Fluorophenyl)methyl]-2-nitro-1,4-benzenediamine, CAS: 150812-21-8, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂FN₃O₂.
N4-[(4-Fluorophenyl)methyl]-2-nitro-1,4-benzenediamine-d4, CAS: /, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈D₄FN₃O₂.
Retigabine, CAS: 150812-12-7, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈FN₃O₂.
Retigabine (1.0 mg/mL in Acetonitrile), CAS: 150812-12-7, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈FN₃O₂.
Retigabine N-β-D-Glucoside, CAS: 229970-69-8, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈FN₃O₇.
Retigabine N-β-D-Glucuronide Sodium Salt, CAS: /, stock: 3.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅FN₃NaO₈.
Retigabine-d4 Dihydrochloride, CAS: 1285886-70-5, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆D₄Cl₂FN₃O₂.
Retigabine-d4 N-β-D-Glucuronide, CAS: /, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂D₄FN₃O₈.
(2E)-4-Chloro-3-methyl-2-butenenitrile, CAS: 25163-39-7, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆ClN.
(2E,4E)-3-Methyl-5-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2,4-pentadienal, CAS: 25528-87-4, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀O.
(2E,4E)-3-Methyl-5-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2,4-pentadienenitrile, CAS: 20109-91-5, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉N.
(4-Nitro-1H-pyrazol-1-yl)acetic Acid, CAS: 6645-69-8, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅N₃O₄.
11,12-Didehydro Retinol, CAS: 29443-88-7, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O.
11-cis-13,14-Dihydro Retinol (~80%), CAS: 879295-61-1, stock: 7.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O.
11-cis-3,4-Didehydro Retinal, CAS: 41470-05-7, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O.
11-cis-Retinal (>65%), CAS: 564-87-4, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O.
11-cis-Retinal (>65%), in Benzene (0.5mg/mL), CAS: 564-87-4, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O.
11-cis-Retinal-d5, CAS: 1217234-58-6, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃D₅O.
13-cis-Retinal 95%, CAS: 472-86-6, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O.
13-cis-Retinal-14,15-13C2, CAS: /, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈¹³C₂H₂₈O.
13-cis-Retinonitrile, CAS: 20638-89-5, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇N.
13-cis-Retinonitrile-13C2, CAS: /, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈¹³C₂H₂₇N.
13-Z-4-Hydroxyretinal, CAS: 71423-68-2, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₂.
15,15’-cis-β,β-Carotene, CAS: 19361-58-1, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₅₆.
3,4-Dehydro-β-ionone, CAS: 1203-08-3, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈O.
3-Dehydro Retinal, CAS: 472-87-7, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O.
4-Fluoro-7-nitro-2,1,3-benzoxadiazole, CAS: 29270-56-2, stock: 2.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂FN₃O₃.
5-Nitro-1H-pyrazole-3-carboxylic Acid, CAS: 198348-89-9, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃N₃O₄.
9-cis-Retinal, CAS: 514-85-2, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O.
9-cis-Retinal-14,15-13C2, CAS: /, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈¹³C₂H₂₈O.
9-cis-Retinal-d5, CAS: 1217234-58-6, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃D₅O.
9-cis-Retinol Acetate, CAS: 29584-22-3, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₂.
9-cis-Retinol Acetate-d5 (>80%), CAS: 1217219-62-9, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇D₅O₂.
all-trans-Retinal-14,15-13C2, CAS: /, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈¹³C₂H₂₈O.
all-trans-Retinal-d5, CAS: 1217234-58-6, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃D₅O.
all-trans-Retinonitrile, CAS: 20638-88-4, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇N.
all-trans-Retinonitrile-14,15-13C2, CAS: /, stock: 7.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈¹³C₂H₂₇N.
all-trans-Retinonitrile-d5, CAS: /, stock: 5.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂D₅N.
BI-78D3, CAS: 883065-90-5, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉N₅O₅S₂.
Bovine RGR (RPE-retinal G protein-coupled receptor) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bovine RLBP1 (Retinaldehyde-binding protein 1) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Chebulinic Acid, CAS: 18942-26-2, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₃₂O₂₇.
HIOC, CAS: 314054-36-9, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉N₃O₃.
Human ABCA4 (Retinal-specific ATP-binding cassette transporter) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human ALDH1A1(Retinal dehydrogenase 1) ELISA Kit (96T), CAS: /, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
(5Z)-5-(5-Chloro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4-oxo-2-thioxo-3-thiazolidinepropanoic Acid, CAS: 1426138-42-2, stock: 1.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₉ClN₂O₄S₂.
